Intermittent hypercapnia induces long-lasting ventilatory plasticity to enhance CO₂ responsiveness to overcome dysfunction by Mosher, Bryan Patrick
INTERMITIENT HYPERCAPNIA INDUCES LONG-LASTING VENTILATORY PLASTICITY 
TO ENHANCE C02 RESPONSIVENESS TO OVERCOME DYSFUNCTION 
RECOMMENDED: 
APPROVED: 
By 
Bryan Patrick Mosher 
or 
dvisory Comm· tee Member 
-~~~ 
Dr. Karsten Huetter 
A 
Advisory Committee Member 
Dr. Michael B. Harris 
Advisory Committee Chair 
r. John C. Eichelberger 
Dean oft2;7;~ool 
Datfl: I I 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTERMITTENT HYPERCAPNIA INDUCES LONG-LASTING VENTILATORY PLASTICITY  
TO ENHANCE CO2 RESPONSIVENESS TO OVERCOME DYSFUNCTION 
 
 
A 
 
DISSERTATION 
 
 
 
Presented to the Faculty 
 
of the University of Alaska Fairbanks 
 
 
 
in partial fulfillment of the requirements 
 
for the Degree of 
 
 
 
DOCTOR OF PHILOSOPHY 
 
 
 
By 
 
Bryan Patrick Mosher, B.A. 
 
 
 
Fairbanks, Alaska 
 
 
 
May 2014 
 
 
v 
Abstract 
The ability of the brain to detect (central CO2 chemosensitivity) and respond to (central 
CO2 chemoresponsiveness) changes in tissue CO2/pH, is a homeostatic process essential 
for mammalian life. Dysfunction of the serotonin (5-HT) mechanisms compromises venti-
latory CO2 chemosensitivity/responsiveness and may enhance vulnerability to patholo-
gies such as the Sudden Infant Death Syndrome (SIDS). The laboratory of Dr. Michael Har-
ris has shown medullary raphé contributions to central chemosensitivity involving both 5-
HT- and γ-aminobutyric acid (GABA)-mediated mechanisms. I tested the hypothesis that 
postnatal exposure to mild intermittent hypercapnia (IHc) induces respiratory plasticity, 
due in part to strengthening of bicuculline- and saclofen-sensitive mechanisms (GABAA 
and GABAB receptor antagonists respectively). Rats were exposed to IHc-pretreatment (8 
cycles of 5 % CO2) for 5 days beginning at postnatal day 12 (P12). I subsequently assessed 
CO2 responsiveness using an in situ perfused brainstem preparation. Hypercapnic re-
sponses were determined with and without pharmacological manipulation. In addition, 
IHc-pretreatment effectiveness was tested for its ability to overcome dysfunction in the 
CO2 responsiveness induced by a dietary tryptophan restriction. This dysfunctional CO2 
responsiveness has been suggested to arise from a chronic, partial 5-HT reduction im-
parted by the dietary restriction. Results show IHc-pretreatment induced plasticity suffi-
cient for CO2 responsiveness despite removal of otherwise critical ketanserin-sensitive 
mechanisms. CO2 responsiveness following IHc-pretreatment was absent if ketanserin 
was combined with bicuculline and saclofen, indicating that the plasticity was dependent 
vi 
upon bicuculline- and saclofen-sensitive mechanisms. IHc-induced plasticity was also ca-
pable of overcoming the ventilatory defects associated with maternal dietary restriction. 
Duration of IHc-induced plasticity was also investigated and found to last far into life (up 
to P65). Furthermore, I performed experiments to investigate if IHc-induced plasticity was 
more robust at a specific developmental period. No such critical period was identified as 
IHc-pretreatment induced robust respiratory plasticity when administered at all develop-
mental periods tested (P12-16, P21-25 and P36-40). I propose that IHc-induced plasticity 
may be able to reduce the severity of reflex dysfunctions underlying pathologies such as 
SIDS. 
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Chapter 1 
Introduction 
1.1 Overview of central control of breathing 
Breathing is an essential homeostatic process that allows precise regulation of oxygen 
(O2) and carbon dioxide (CO2) concentrations in blood and tissues. Within the medulla of 
the mammalian brainstem exist vital circuits that control respiratory movements and 
maintain homeostasis of the brain and body. The seemingly simple, automatic process of 
breathing is in fact the result of complex neural mechanisms.  
 Respiration is thought to arise from two independent oscillators located within 
the ventrolateral medulla: the pre-Bötzinger complex (pre-BötC) that is widely considered 
to be the inspiratory kernel (Smith et al., 1991), and the retrotrapezoid nucleus/parafacial 
respiratory group (RTN/pFRG) that plays a major role in active expiration (Fig. 1.1). The 
subset of pre-BötC neurons thought to be responsible for inspiration possess intrinsic 
bursting properties with two main underlying mechanisms. The first is dependent upon 
sub-threshold activation of persistent Na+ current (INaP) in neurons with sufficiently low 
leakage-like K+ current and is voltage sensitive (Koizumi and Smith, 2008; Del Negro et al., 
2002; Butera et al., 1999). The second bursting mechanism is less voltage sensitive and 
depends on Ca2+-activated nonspecific cationic current (ICAN), whose activation mecha-
nism in the absence of synaptic input depends on voltage-gated Ca2+ channels (Smith et 
2 
al., 2007). This pre-BötC neuronal population drives inspiratory activity through projec-
tions to various premotor populations, such as the rostral ventral respiratory group 
(rVRG) and the parahypoglossal (pXII) group, that in turn project both to inspiratory mus-
cles that pump air, mainly the diaphragm and external intercostals, and to inspiratory 
muscles that modulate airflow resistance, such as laryngeal and tongue muscles (Feldman 
et al., 2012). 
 At rest, expiration is generated passively due to the forces generated by the elastic 
recoil of the inspiratory muscles, lung and rib cage. However, during situations such as 
exercise, encountering an elevated CO2 stimulus or a powerful emotional response, non-
chemosensitive neuronal populations in the RTN/pFRG region are activated and function 
to generate active expiration. The RTN/pFRG drives active expiratory activity through pro-
jections to various premotor populations, such as the caudal ventral respiratory group 
(cVRG) and the pXII group, which in turn project both to expiratory pump muscles, ab-
dominals and internal intercostals, and to expiratory muscles that modulate airflow re-
sistance, such as laryngeal and tongue muscles (Feldman et al., 2012). 
The RTN/pFRG and preBötC, together, act as coupled oscillators, and comprise the 
central rhythm generator (CRG), which produces respiratory rhythm. In addition, several 
neuronal populations interact with the pFRG and preBötC to modulate respiratory output 
(Figs. 1.1 and 1.2). One such modulatory input to the respiratory CRG is the central re-
sponse to CO2, known as central chemoreception. 
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Cells that possess central CO2 chemoreception abilities are acid-sensing and stim-
ulated by CO2/pH in the blood, cerebral spinal fluid or tissue. When blood CO2 levels in-
crease, CO2 diffuses across the blood brain barrier capillaries to equilibrate with cerebral 
spinal fluid or tissue and the resulting acidosis stimulates chemoreceptors. The result of 
such stimulation, referred to as the hypercapnic ventilatory response (HCVR), varies de-
pending on neuron type, however, the eventual output triggers an increase in respiratory 
rate and amplitude. The HCVR is a critical reflex in mammals and is essential for the 
maintenance of homeostasis. Several regions in the brainstem have been identified at 
potential sites of CO2 chemoreception. 
In the medullary raphé nuclei of the brainstem, a subset of serotonin (5-hydroxy-
tryptamine or 5-HT) -synthesizing neurons act as central respiratory chemoreceptors 
(CRCs). The medullary raphé provides tonic modulatory input to the respiratory network 
through 5-HT neuronal activation (Corcoran et al., 2009). However, depending on the an-
imal model, experimental preparation and developmental period, 5-HT receptor activa-
tion is capable of eliciting either excitatory or inhibitory effects on respiratory control.  
 
1.2 Introduction to central CO2 chemosensitivity 
CO2-sensitive central chemoreceptors provide critical sensory information, which affects 
synaptic drive necessary for rhythm generation and modulates respiratory pattern to pro-
tect the brain from excessive changes in CO2 and pH. 
4 
Breathing depends on input from chemoreceptors, which provide the essential 
information about O2, CO2 and pH (Nattie, 1999). The majority of O2-sensitive chemore-
ceptors are located outside the brain in the carotid bodies. CO2/pH-sensitive chemore-
ceptors are found in the carotid bodies, however, major sites are also within the brain 
and are referred to as CRCs. CO2/pH signals are related to the acid-base status of the 
blood and brain and even small changes in CO2/pH can affect breathing.  
To be considered a chemoreceptor, a neuron must not only be chemosensitive, 
but it must also be intrinsically chemosensitive, or responsive to pH/CO2 change without 
input from another chemoreceptor. In addition, this network-independent chemosensi-
tivity must also occur over a physiologically relevant range of CO2 concentrations and pH, 
and ultimately modulate ventilatory output to rectify the pH homeostatic challenge.  
Central CO2 chemosensitivity is considered a complex system function that in-
volves a limited but varied group of neuron types, brain stem sites and multiple neuro-
transmitter mechanisms (Fig. 2; Feldman et al., 2003; Nattie, 2009; Nattie and Li, 2009; 
Putnam et al., 2004). Although much controversy surrounds the critical center for central 
CO2 chemosensitivity, research has yet to definitively identify such a region. The wide 
range of findings concerning central CO2 chemosensitivity may be due to the numerous 
ways in which it is investigated. Differences in experimental preparations (in vivo, in situ 
or in vitro) can have significant effects on conclusions drawn about central chemosensi-
tivity, and with each preparation comes its own limitations. Because CRCs are likely in-
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volved in complex networks, and the necessity of isolating populations of intrinsic chem-
oreceptors, experimental isolation in vivo can be very challenging. In an attempt to over-
come such limitations, various experimental preparations are commonly utilized when 
drawing conclusions about central respiratory chemoreception.   
Discrete sites that are very sensitive to small changes in pH function in concert to 
establish system CO2 chemosensitivity. Many cell types and molecular mechanisms are 
involved in the process of CO2 chemoreception. Examples of potential pH-sensitive pro-
teins present at many chemoreceptor locations include (i) low resistance gap junctions 
(Solomon et al., 2001); (ii) TWIK-related acid-sensing K+ (TASK) channels, such as transient 
receptor potential channel canonical subfamily 4 (TRPC4) and 5 (TRPC5; Cui et al., 2011; 
Semtner et al., 2007); (iii) inward rectifier K+ channels (Jiang et al., 2001); and (iv) pH-
sensitive membrane ion transport proteins, such as the Na+/H+ exchange protein subtype 
3 (NHE3), which may modulate CO2 chemosensitivity by altering the degree and timing of 
intracellular pH changes (Putnam, 2001). In addition, it is possible that more than one pH-
sensing function may operate simultaneously. Neurotransmitters and neuromodulators 
that are involved in the central response to CO2 include orexin, adenosine triphosphate 
(ATP), thyrotropin releasing hormone (TRH), noradrenalin, substance P (SP), 5-HT, γ-ami-
nobutyric acid (GABA) and glutamate, in gaseous neurotransmitters (e.g., nitric oxide). 
The receptors for these neurochemicals are located postsynaptically on chemoreceptors 
in the brainstem (Hodges and Richerson, 2010b; Huckstepp and Dale, 2011; Putnam, 
2001). 
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1.3 Raphé 5-HT and GABA neurons as CO2 chemosensors  
In addition to being sensitive to small changes in pH, medullary 5-HT neurons have a con-
venient relationship with blood vessels that affords them a specialized role as arterial CO2 
sensors (Bradley et al., 2002). Most of the blood flow to the medulla travels through the 
midline raphé in branches of the basilar artery (Fig. 1.3). Partial pressure of CO2 (PCO2) 
within the raphé closely reflects the PCO2 of blood coming out of the lungs as there is a 
high density of large arteries in this region, and they are located proximal to the arterial 
tree, which is one of the first branches after leaving the heart. 5-HT neuronal dendrites 
wrap around the walls of the large midline arteries which allows them to take full ad-
vantage of the vascularity in this location. Amazingly, in some cases the dendrites come 
within one half of a micrometer from the vessel lumen. The unique relationship between 
raphé neurons and large arteries is thought to provide a functional advantage allowing 
the brain to monitor the PCO2 of blood after it has come out of the lungs, and before 
being influenced by brain metabolism (Bradley et al., 2002). This amazingly convenient 
design is an excellent way to monitor the effectiveness of lung ventilation and prevent 
sudden increases in brain PCO2. 
A subset of medullary raphé neurons is highly sensitive to changes in CO2 and pH. 
In rat brain slices, some medullary raphé neurons are strongly stimulated by an increase 
in PCO2 from 33 mmHg to 60 mmHg, and are inhibited by a decrease in PCO2 from 33 
mmHg to 23 mmHg (Richerson, 1995). Despite this finding, most medullary raphé neurons 
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do not respond to changes in PCO2 within these ranges and most medullary raphé neu-
rons are not serotonergic. In order to eliminate the effects of synaptic input, increase 
recording stability and have enhanced experimental control, chemosensitive medullary 
raphé neurons can be isolated in tissue culture. Consistent with findings in brain slices, a 
subset of raphé neurons in culture is stimulated by increased CO2. However, a different 
subset of neurons is inhibited by the same CO2 stimulus. In addition, the morphologies of 
these two types of chemosensitive neurons are different, indicating that they are pheno-
typically distinct (Wang et al., 1998). This possibility was further solidified by the finding 
that all CO2-stimulated neurons from the medullary raphé, but none of the CO2-inhibited 
neurons, are serotonergic (Wang et al., 2001). In addition to acidosis-stimulated 5-HT 
neurons found in the raphé, in vitro analyses have identified the acidosis-inhibited popu-
lation of neurons as being GABAergic (Iceman et al., 2010; Wang et al., 1998). Despite 
much evidence indicating that the raphé nuclei in the medulla possess network-independ-
ent intrinsic chemosensitivity in vitro (Corcoran et al., 2009; Hodges and Richerson, 
2010a), the role of raphé neurons in chemosensitivity in vivo is a topic of ardent debate. 
Despite much disagreement concerning what types of neurons are the critical 
chemosensors, much evidence suggests that 5-HT neurons play a role in chemosensitivity 
(Richerson, 2004). Because 5-HT neurons are intrinsically chemosensitive in vitro, are 
stimulated by hypercapnia in vivo and this response is attenuated when 5-HT neurons are 
disrupted, 5-HT neurons are thought to function as chemoreceptors. Further strengthen-
ing the case for 5-HT neurons as chemosensors is that when the 5-HT2 receptor antagonist 
8 
ketanserin is applied in situ, the response to hypercapnia is abolished (Corcoran et al., 
2013). In addition in vivo inhalation of CO2 increases c-Fos staining in the medullary raphé 
of cats (Larnicol et al., 1994). This finding was later confirmed and extended when it was 
shown that CO2-activated neurons in the medulla of rats are immunoreactive for 5-HT 
and tryptophan hydroxylase (Haxhiu et al., 2001; Johnson et al., 2003). Furthermore, mi-
croinjection of azetazolamide, a carbonic anhydrase inhibitor that acts to induce tissue 
acidosis, causes an increase in breathing when focally injected in the medullary raphé of 
rats (Bernard et al., 1996). Later experiments demonstrated that ventilation in rats is also 
stimulated by microdialysis of a high CO2 solution in the medullary raphé (Nattie and Li, 
2001). Further demonstrating their role as chemoreceptors, lesioning medullary 5-HT 
neurons leads to blunting of the response to hypercapnia (Richerson, 2004). Additionally, 
rats exhibit a depressed hypercapnic response when serotonergic neurons in the medul-
lary raphé are inhibited using 8-OH-DPAT, a 5-HT1A receptor antagonist (Messier et al., 
2004). 
In addition, several genetic methods have been used to investigate 5-HT and its 
role in the response to CO2. Pet-1 knockout mice, which lack ≈ 70 % of 5-HT neurons, 
display reduced CO2 sensitivity in males but not females (Hodges et al., 2011). Further-
more, neonatal mice with genetic deletion of Lmx1b in neurons expressing Pet-1 
(Lmx1bf/f/p), which have a selective and severe deficit (> 99 %) in 5-HT neurons, display a 
≈ 50 % reduction in the hypercapnic ventilatory response (Hodges and Richerson, 2008; 
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Hodges et al., 2008). These examples of various levels of 5-HT neuron reductions further 
demonstrate the important role that 5-HT plays in the response to hypercapnia.  
Despite the impressive body of research on 5-HT raphé as chemosensors, this hy-
pothesis does not imply that 5-HT or any raphé neurons are the exclusive sensory trans-
ducers of hypercapnia in the brain. Instead, it is more likely that they are one component 
of what is probably a network of chemosensitive brain sites (Richerson, 2004). 
 
1.4 Push-pull model of raphé chemosensitivity  
The laboratory of Dr. Michael Harris has developed a model describing raphé contribu-
tions to central CO2 chemosensitivity wherein both 5-HT and GABA mechanisms modulate 
ventilation to maintain tissue CO2/pH through synaptic activation and disinhibition, re-
spectively (Fig. 1.4; Corcoran et al., 2008; Richerson, 1995). We have demonstrated that 
these cell types retain CO2 chemosensitivity in the intact and unanesthetized brainstem 
(Corcoran et al., 2008, 2013; Iceman et al., 2013).  
Hypercapnia stimulates raphé 5-HT neurons and activates CRGs and motor neuron 
pools (MNP), which causes an increase in ventilation. Under normocapnic conditions (nor-
mal levels of CO2), GABA raphé neurons provide tonic inhibitory input to raphé 5-HT neu-
rons, MNPs and CRGs. However, when exposed to hypercapnia, GABA neurons are inhib-
ited. This inhibition of GABA neurons disinhibits the 5-HT cells, MNPs and CRGs, leading 
to an eventual stimulation of ventilation. When exposed to low levels of CO2 (hypocap-
nia), 5-HT neuron drive is inhibited and GABA neurons are excited.  This excitation of 
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GABA neurons has an inhibitory influence on 5-HT neurons, MNPs and CRGs. The com-
bined inhibition of 5-HT neurons and excitation of GABA neurons brought on by hypocap-
nic conditions leads to a depression of ventilation.  
 
1.5 Evidence for other central CO2 chemoreceptors 
There is strong evidence that there are additional central CO2 chemoreceptors located in 
other brainstem nuclei besides the raphé, including the RTN, locus coeruleus (LC), nucleus 
tractus solitarious (NTS), lateral hypothalamus and cerebellum. Central CO2 chemosensi-
tivity is considered a complex system function that involves several brain stem sites (Fig. 
1.1; Feldman et al., 2003; Nattie, 2009; Nattie and Li, 2009; Putnam et al., 2004). The RTN 
is well-established as being important in respiratory control and central CO2 chemorecep-
tion (Feldman et al., 2003; Guyenet et al., 2005; Li and Nattie, 1997). RTN neurons have a 
large response to CO2 inhalation in vivo (Mulkey et al., 2004), however, because it is not 
known how much of their response is intrinsic, it remains unclear how important these 
neurons are as chemoreceptors (Corcoran et al., 2009). Given that several neuronal 
groups function in the response to hypercapnia, if one chemosensory region is rendered 
dysfunctional as a result of injury or disease, other regions may be able to compensate to 
mediate an appropriate response. 
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1.6 Breathing disorders associated with 5-HT dysfunction 
Serotonin plays an important role as a signaling molecule, acting as a neurotransmitter in 
all species of the animal kingdom (Azmitia, 2007; Berger et al., 2009). In the mammalian 
central nervous system (CNS), the relatively small number of serotonergic neurons are 
located near and along the midline of the brainstem. Despite being a small population, 
these few neurons have projections to target regions throughout the entire neuraxis. The 
effects of 5-HT, and co-released neuropeptides such as SP and TRH, depend upon their 
combination of receptors, the second messenger systems and the developmental stage 
in which they are expressed. With diverse projections and numerous pre- and post-syn-
aptic receptor subtypes, it is not surprising that the 5-HT system has been proposed to 
contribute to numerous brain functions and pathologies. These include, but are not lim-
ited to, neurogenesis, synaptic plasticity, brain homeostasis, sleep and circadian rhythms, 
appetite, pain, thermoregulation, micturition, addiction, migraine, depression, fear and 
anxiety, aggression and rage, learning and memory, obsessive compulsive disorder, schiz-
ophrenia, Prader-Willi syndrome, autism, and breathing disorders such as Sudden Infant 
Death Syndrome (SIDS), sleep apnea and Congenital Central Hypoventilation Syndrome 
(CCHS). 
Research on SIDS victims has uncovered an abnormality in the medullary sero-
tonergic system (Kinney et al., 2001), including the medullary raphé (Panigrahy et al., 
2000). This evidence supports the hypothesis that SIDS victims are not normal prior to 
death, despite appearing to be in good health (Filiano and Kinney, 1994). In one study of 
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84 cases at The Boston Children’s Hospital over a 10-year period (1985–1995), mean 5-
HT binding was analyzed in 52 SIDS cases (cause of death undetermined), 15 acute con-
trols (cause of death established at autopsy) and 17 chronic controls (deaths attributed 
to known oxygenation disorders) (Panigrahy et al., 2000). Nineteen brainstem nuclei, in-
cluding the medullary raphé, were analyzed for [3H]-lysergic acid diethylamide ([3H]-LSD) 
binding, a 5-HT receptor agonist binding to 5HT1A-D and 5HT2 receptors. Results indicated 
reduced 5-HT receptor binding in the raphé compared to either the acute controls or 
chronic controls. The 50–60 % decrease in mean 5-HT receptor binding found suggests an 
abnormality in the medullary raphé of SIDS victims (Panigrahy et al., 2000). Because the 
raphé is involved in the modulation of a variety of homeostatic processes, including res-
piratory control, abnormalities in this brainstem region could prevent a vulnerable infant 
from responding to a life-threatening challenge, such as hypercapnia, during sleep.  
A “Triple Risk Model” has been suggested as an appropriate method in which to 
describe the interaction of multiple factors in the pathogenesis of SIDS (Filiano and Kin-
ney, 1994). According to this model, SIDS results when three factors simultaneously influ-
ence an infant: (a) an underlying vulnerability in the infant, (b) a critical developmental 
period and (c) an exogenous stressor, e.g., prone sleep position (Fig. 1.5). In the context 
of the Triple Risk Model, the risk factors for SIDS can be divided into extrinsic and intrinsic 
categories. Extrinsic risk factors are acquired physical stressors related to the circum-
stances of death, e.g., prone sleep position. Such exogenous stressors are postulated to 
induce asphyxia, hypercapnia and hypoxia. Intrinsic risk factors, however, are associated 
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with the underlying vulnerability/abnormality in the infant and increase the likelihood of 
SIDS by exacerbating this abnormality. The intrinsic risk factors include prematurity, male 
gender, African American race, poverty, adverse prenatal factors such as maternal smok-
ing or alcohol use during pregnancy and genetic polymorphisms (Iyasu et al., 2002; Moon 
et al., 2007). The critical period for SIDS (the first six months of life) coincides with dra-
matic and rapid changes in the respiratory control system (Filiano and Kinney, 1994). Ac-
cording to the Triple Risk Model, only infants with an underlying brainstem abnormality 
die of SIDS. Because not all infants have an underlying brainstem abnormality, this ex-
plains why not all infants who are put to sleep in the prone position or who bed share die 
of SIDS. The model also explains why SIDS rates are reduced by the change to supine sleep 
position: The exogenous stressor is removed, which allows the vulnerable infant to pass 
through the critical period unharmed.  
Sleep-disordered breathing, sleep apnea, is the periodic cessation of breathing 
during sleep. Approximately 5 % of middle-aged males and 2 % of children have sleep-
disordered breathing (Bixler et al., 2001; Gaultier, 2001). Sleep apnea is associated with 
age-related dysfunction in the 5-HT system (Kubin et al., 1998). These defects could un-
derlie deficits in upper airway tone during sleep, leading to apneas. 
 Central chemoreception is absent or reduced in children with CCHS (Spengler et 
al., 2001). These children function relatively normally during wakefulness but require ven-
tilatory support during sleep to avoid very high CO2 and low O2 levels due to inadequate 
ventilation. Mutation of the human Phox2b gene has been identified in patients suffering 
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from CCHS. An animal model suggests that CCHS is due to a Phox2b gene mutation that 
deletes neurons expressing this transcription factor in the RTN/pFRG (Thoby-Brisson et 
al., 2009). This reduces phrenic nerve activity, alters respiratory frequency and attenuates 
system responses to CO2. 
Respiratory insufficiency is the major cause of morbidity and mortality in spinally 
injured patients (Ramer et al., 2000). Serotonin-dependent plasticity may play a critical 
role in spontaneous and induced functional recovery following spinal cord injury (Golder 
et al., 2001). Additional respiratory disorders have implicated 5-HT in their pathophysio-
logical mechanism, including panic anxiety hyperventilation disorders (Klein, 1996) and 
ventilatory instability in Rett Syndrome (Dunn and MacLeod, 2001).  
 
1.7 The role of nutrition in breathing disorders 
During development, the respiratory control system is known to be sensitive to a variety 
of environmental perturbations, including psychological stress (maternal separation), 
chronic changes in respiratory gases (hypoxia, hyperoxia, hypercapnia), numerous drugs 
such as caffeine, nicotine, alcohol, (Bavis and Mitchell, 2008) and nutrition, especially ma-
ternal nutrition (Penatti et al., 2011).  
 Protein malnutrition affects a large population of infants, especially in developing 
countries. Several ontogenic steps of brain development such as neuronal proliferation 
and migration, brain growth spurt and myelination are altered by protein malnutrition in 
animal models (Gressens et al., 1997). Penatti et al. (2011) provided female rats with 
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chow containing 45 % less of the essential amino acid tryptophan, the essential precursor 
for 5-HT, than normal chow. Consequently, when these rats were bred, their offspring 
experienced low tryptophan availability throughout gestation and postnatal develop-
ment. The tryptophan-restricted pups exhibited significantly reduced brainstem levels of 
5-HT as expected, but they also exhibited a partially blunted response to hypercapnia. 
This observation confirms that a mother’s nutritional status can influence her offspring’s 
respiratory control system, at least during the neonatal period. These findings also indi-
cate that malnutrition may be a mechanistic link between poverty and increased SIDS risk 
(Bavis, 2011). Part of my research repeated the dietary restriction utilized by Penatti et 
al. (2011) to induce a partial chronic 5-HT reduction. This was done to test the efficacy of 
a treatment aimed to reverse or combat the ventilatory dysfunction imparted by the 5-
HT reduction.  
 
1.8 Plasticity within central respiratory chemosensitivity 
Plasticity is a unique and fundamental characteristic of neural systems enabling animals 
to adapt to changes in environmental conditions and behavior. Plasticity is a persistent 
change in the morphology and/or function of the neural control system based on prior 
experience. Relevant experiences include neural activity, hypoxia, hypercapnia, injury, 
disease or aging. A considerable amount of research in recent years has revealed that the 
neural mechanisms controlling respiration are capable of exhibiting remarkable plasticity 
(Mitchell and Johnson, 2003).  
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 Central chemoreception is likely best described as a complex system function that 
involves a limited but varied group of neuron types, brainstem sites, and multiple neuro-
transmitter mechanisms (Feldman et al., 2003; Mitchell et al., 1990; Nattie, 2009; Nattie 
and Li, 2009; Putnam et al., 2004). Organization of chemosensitivity as a system function 
affords the potential for considerable plasticity. Not only could a specific mechanism play 
a differential role in overall system sensitivity under specific conditions, the involvement 
of multiple mechanisms may allow homeostatic regulation despite partial dysfunction, 
injury or disease (Feldman et al., 2003). 
 Various protocols using different chemoreceptor stimuli (hypoxia and hypercap-
nia), durations, intensities and patterns have been shown evidence of inducing distinct 
forms of plasticity in respiratory control. These resulting forms of plasticity differed in 
their effect (facilitation or depression) on different ventilatory parameters. In addition, 
the duration over which plasticity is evoked has been quite variable, ranging from seconds 
to years (Moore, 2000; Wagner and Eldridge, 1991). With such a wide range of plasticity 
being the result of the aforementioned protocols, it appears that the specific stimulus 
paradigm seems to be of great importance.  
Hypoxia-induced respiratory plasticity is widely considered to be the most thor-
oughly studied and best understood form of respiratory plasticity. Depending on the spe-
cific hypoxia protocol, various forms of plasticity may be induced. In anesthetized rats, 
after a single hypoxic episode, a short-term depression of phrenic motor output (post-
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hypoxia frequency decline) is observed (Coles and Dick, 1996). However, when intermit-
tent hypoxia is administered, various unique forms of plasticity are induced. Elevated res-
piratory activity during normoxic exposures between successive hypoxic episodes is often 
observed, reflecting the development of long-term facilitation (LTF; Powell et al., 1998). 
Persistent elevation of respiratory motor output, lasting minutes to hours, is the result of 
3-10 hypoxic episodes with each episode duration varying depending on experimental 
protocol (Mitchell et al., 2001). Furthermore, LTF is elicited by intermittent, but not con-
tinuous, hypoxia (Baker and Mitchell, 2000). If intermittent hypoxia persists, different 
mechanisms of plasticity are evoked. For example, chronic intermittent hypoxia augments 
the short-term hypoxic ventilatory response, eliminates post-hypoxia frequency decline 
and enhances LTF in rats (Ling et al., 2001). Just as different hypoxic stimulus protocols 
vary in their capacity to evoke respiratory plasticity, hypercapnic stimulus protocols also 
induce respiratory plasticity to varying degrees. 
Although receiving less attention, and relatively poorly understood, hypercapnia 
is also capable of eliciting various forms of respiratory plasticity. In contrast to intermit-
tent hypoxia, intermittent hypercapnia (≈ 10 % inspired CO2) elicits long-term depression 
(LTD), a long-lasting decrease in the frequency and amplitude of respiratory motor output 
(Bach and Mitchell, 1998). However, LTD is not evoked by less severe levels of hypercap-
nia (≈ 5 %). In contrast to the previous report by Bach and Mitchell (1998), Baker et al. 
(2001) found that intermittent hypercapnia did not elicit significant LTD of phrenic ampli-
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tude, but significant LTD of burst frequency was resolvable. In contrast to episodic hyper-
capnia, Baker et al. (2001) found that continuous hypercapnia did elicit prolonged LTD. 
Steggerda et al. (2009) examined the effects of daily exposure to intermittent hypercap-
nia on the ventilatory response to subsequent hypercapnic and hypoxic exposure in neo-
natal rat pups. In response to a subsequent hypercapnic challenge, there was no signifi-
cant difference in the ventilatory response between control and intermittent hypercap-
nia-exposed groups. In contrast, intermittent hypercapnia-exposed rat pups exhibited an 
enhanced ventilatory response to hypoxic challenge with an increase in minute diaphrag-
matic electromyogram (EMG; Steggerda et al., 2009). In addition, rat pups that were ex-
posed to perinatal hypercapnia exhibited only a transient reduction in the hypercapnic 
ventilatory response (Bavis et al., 2006). Collectively, these data suggest that the duration, 
intensity and pattern of chemosensory stimuli protocol utilized are of great importance 
when investigating the respiratory plasticity evoked by both hypoxia and hypercapnia. 
One aspect of my studies was dedicated to the investigation of respiratory plasticity in-
duced after administration of an intermittent hypercapnia protocol during a specific de-
velopmental period in rats.  
  
1.9 Potential mechanisms of respiratory plasticity 
Although detailed cellular or synaptic mechanisms surrounding respiratory plasticity are 
yet to be revealed, several mechanisms have been suggested. It may be that respiratory 
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plasticity is induced by previous activity at a synapse, known as “activity-dependent syn-
aptic plasticity.” While high-frequency activity is capable of enhancing synaptic transmis-
sion for hours to days (LTP; Bach and Mitchell, 1996; Malenka and Nicoll, 1999), low-fre-
quency activity may decrease synaptic strength for minutes to hours (LTD; Fig. 1.6; Kemp 
and Bashir, 2001). In another form of plasticity, neurochemicals such as 5-HT, norepineph-
rine or trophic factors such as brain-derived neurotrophic factor (BDNF) may initiate or 
regulate synaptic plasticity, termed “neuromodulator-induced synaptic plasticity” (Fig. 
1.6; Kinkead et al., 2001; Kovalchuck et al., 2002). In addition, it may be that existing, but 
ineffective, synaptic pathways or “silent synapses” are enhanced by experimental manip-
ulations or injury resulting in respiratory plasticity (Fig. 1.6; Poncer and Malinow, 2001). 
Furthermore, respiratory plasticity may be induced by altered concentrations of neuro-
modulators near their targets, which may cause changes in the activity of neuromodula-
tory neurons, the number and size of neuromodulatory terminals, reuptake of neuromod-
ulator once released, or synthesis and degradation of neuromodulators. In addition, plas-
ticity also depends on the density and type of receptors on pre- and postsynaptic targets, 
as well as their intracellular signaling mechanisms (Fuller et al., 2002). Also, plasticity may 
be induced by changes in neuronal properties such changes in soma and dendrite 
size/shape (Fig. 1.7), alterations in membrane potential, input resistance, capacitance and 
action potential threshold (Cameron and Nunez-Abades, 2000; Luscher and Frerking, 
2001). Further yet, plasticity may be due to the formation of new synaptic connections 
between existing neurons (Fig. 1.7; Cameron and Nunez-Abades, 2000). 
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1.10 Critical periods in the development of central CO2 chemosensitivity 
The development of the respiratory control system is complex and consists of dynamic 
interactions that begin early in gestation and, in mammals, does not achieve maturity 
until weeks or months after birth. In addition to its elaborate interactions and connec-
tions, the respiratory control system is capable of exhibiting plasticity induced by experi-
ence or training during “critical” periods of development. That is, the same experience 
occurring outside of the critical period has little or no lasting effect, indicating that the 
plasticity depends on time windows during ontogeny when development can be altered 
in response to the external environment. Thus, developmental exposure to numerous ex-
periences such as episodic or chronic hypoxia, hyperoxia, hypocapnia or hypercapnia, or 
drug or toxin exposures may cause disruption of neural respiratory control maturation. 
 The development of central CO2 chemosensitivity also appears to develop with a 
shift in the degree of responsiveness to CO2. Wang and Richerson (1999) observed in me-
dullary slices that the percentage of neurons stimulated by hypercapnia was significantly 
greater in slices from rats older than P12 compared to younger rats. In addition, these 
findings paralleled to those found in medullary raphé neurons in tissue culture (Wang and 
Richerson, 1999). These findings may reflect the suggested critical period described by 
the transient imbalance between excitatory and inhibitory neurotransmission at P12 (Liu 
and Wong-Riley, 2002). Given these findings, I chose to administer the intermittent hy-
percapnia protocol for five consecutive days beginning at P12. 
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1.11 The role of peripheral chemosensors 
Both central (brainstem) and peripheral (carotid bodies) respiratory chemoreceptors play 
an important role within the respiratory control system to ensure that blood gases do not 
rise or fall with potentially negative, or even fatal consequences. Peripheral chemorecep-
tors respond to changes in blood gases in 3-5 seconds, which is approximately an order 
of magnitude faster than central chemoreceptors (Carroll et al., 1991). Carotid bodies are 
known to be the primary oxygen sensors but also play an important role in sustaining 
eupneic ventilation under normoxic conditions (Forster et al., 2008). In addition, carotid 
bodies are reported to respond vigorously to changes in PCO2 (Cunningham, 1987). 
 Carotid body afferents mainly terminate on NTS neurons that have reciprocal con-
nections not only with the RTN (a known region of CO2 chemoreception) but also with 
many other neurons within the respiratory network, some of which are also chemosensi-
tive (Rosin et al., 2006; Takakura et al., 2006). Research concerning the role of peripheral 
chemoreceptors is much debated. In general it is thought that peripheral chemoreceptors 
have three potential interaction modes with central chemoreceptors: hypoadditive, ad-
ditive and hyperadditive (Teppema and Smith, 2013). 
 
1.12 Comparison of in vitro, in situ and in vivo CO2 chemosensitivity findings 
Investigators studying central CO2 chemosensitivity are fortunate to have numerous ex-
perimental preparations with which to conduct their studies. Unfortunately the findings 
across all preparations exhibit much variability and at times are inconsistent. With such 
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variable results comes much controversy. Although 5-HT neurons are thought by many to 
play a large role in central chemosensitivity, not everyone is completely convinced. 
 One argument that 5-HT neurons are not central CO2 chemoreceptors is based on 
the assertion that 5-HT neurons do not have a large response to CO2 in vivo (Guyenet et 
al., 2008). Guyenet et al. (2008) based this conclusion on recordings from rats under hal-
othane anesthesia in which 5-HT neurons in the rostral ventrolateral medulla (RVLM) have 
a small hypercapnic response (Mulkey et al., 2004). However, other studies from unanes-
thetized animals have revealed that 5-HT neurons do indeed exhibit a robust response to 
hypercapnia (Veasey et al., 1997). It is challenging to explain why 5-HT neurons would be 
highly chemosensitive in brain slices and in culture (Richerson, 2004), but have little or no 
response in vivo. The most likely explanation for the small CO2 response of 5-HT neurons 
in the RVLM seen in vivo by Mulkey et al. (2004) is the use of halothane (Massey et al., in 
review). Anesthesia is well known to have major effects on respiratory control. The ex-
periments performed by Mulkey et al. (2004) were performed with halothane anesthesia, 
whereas other studies of chemosensitivity of 5-HT neurons in vivo were performed in un-
anesthetized animals (Veasey et al., 1997). This suggests that chemosensitivity of 5-HT 
neurons is blunted or masked by halothane anesthesia. A potential mechanism for this 
effect is that 5-HT neurons abundantly express TASK channels that are relatively inactive 
at rest, but are strongly activated by halothane (Sirois et al., 2000; Washburn et al., 2002). 
This activation could lead to a large current shunt, reducing the effect on membrane po-
tential of changes in other currents, dampening or masking the response to hypercapnia.  
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 In addition, many disagree about which experimental preparation is most benefi-
cial/useful for studying central chemosensitivity. The perfused in situ brainstem prepara-
tion has been suggested to express a lower hypercapnic response than the in vivo prepa-
ration (Day and Wilson, 2009). We, in the laboratory of Dr. Michael Harris, strongly disa-
gree with such a statement. Instead we propose that the two preparations are similarly 
sensitive, but that ventilatory sensitivities cannot be fully resolved is situ, from phrenic 
neurograms alone. We propose that intercostals contribute to enhanced tidal volume 
during respiratory stimulation. Thus, when intercostal recruitment is considered along 
with phrenic activity, the hypercapnic response of the in situ preparation may closely re-
semble that of the in vivo preparation (Harris et al., 2013). 
 
1.13 Specific aim 
The present dissertation describes studies developed to test the efficacy of an intermit-
tent hypercapnia (IHc) protocol hypothesized to combat or reverse the abnormal re-
sponse to hypercapnia associated with 5-HT dysfunction. Two levels of 5-HT dysfunction 
were induced, chronic partial and acute profound. Influences of the IHc protocol were 
assessed for duration of plasticity induced (acute vs. long-lasting) and whether or not 
there was a critical period in which the IHc protocol had its greatest effects. Induced plas-
ticity was hypothesized to be due to an enhancement of GABA mechanisms and pharma-
cological antagonists were used to test this hypothesis. Although pharmacological antag-
onism was used as a preliminary assessment of mechanism of induced plasticity, the aim 
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of the present studies was not to determine the exact cellular/molecular mechanisms in-
volved in this plasticity.  
 
 
1.14 Experimental approach 
The studies described in the current dissertation address the following questions: 1) Is the 
IHc-pretreatment protocol capable of overcoming the abolishment of hypercapnic re-
sponsiveness normally associated with the antagonism of ketanserin-sensitive mecha-
nisms? 2) Is the IHc-pretreatment protocol capable of overcoming the reduced hypercap-
nic responsiveness induced by maternal tryptophan restriction? 3) Is the respiratory plas-
ticity induced with the IHc protocol an acute or long-lasting effect? 4) Is there a critical 
period in which the IHc protocol has its greatest influence? 
 The in situ perfused decerebrate rat brainstem preparation was chosen as the ex-
perimental preparation to investigate the questions asked in this dissertation (Fig. 1.8). 
Used by many groups, this is a powerful preparation that is very useful for the study of 
the respiratory system (Paton, 1996; Toppin et al., 2007). Despite being decerebrate, the 
majority of the central nervous system remains intact, including the brainstem respiratory 
control network. An important advantage of the in situ preparation is the absence, after 
initial dissection, of anesthesia. In addition, the stability of this preparation allows for pro-
longed electrophysiological recordings. Furthermore because the animal is decerebrate 
and insentient, many pharmacological manipulations not possible in vivo are possible. Us-
ing suction electrodes, phrenic neurograms (activity of the phrenic nerve innervating the 
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diagram, which is the major pump muscle involved in respiration) were recorded. To en-
sure consistent recordings, glass micropipettes for suction electrodes were pulled to fit 
the size of the animal being used for the specific experiment being conducted. The re-
sponse to a 4 % hypercapnic challenge (increase from 5 % CO2 in perfusate to 9 %) was 
assessed for each animal. As central structures are more responsible for the response to 
CO2, the preparations were perfused with a high level of oxygen (approximate PO2 of 600 
mmHg) to effectively eliminate any hypercapnic response from peripheral chemorecep-
tors (carotid and aortic bodies). This allowed us to investigate the influences of our IHc 
protocol on central mechanisms.  
 
1.15 Major findings 
Ours is the first reported observation that IHc-pretreatment can influence subsequent  
CO2 chemoresponsiveness. I show that the plasticity induced by IHc-pretreatment is ca-
pable of overcoming the profound CO2 chemoresponsive dysfunction produced by ketan-
serin treatment. With pharmacological antagonism, I show that the enhancement of CO2 
chemoresponsiveness is due to strengthening of bicuculline- and/or saclofen-sensitive 
GABAA/B mechanisms. In addition, IHc-pretreatment is capable of overcoming the mild 
CO2 chemoresponsive dysfunction induced by dietary tryptophan restriction. Further-
more, I show that IHc-pretreatment induces long-lasting respiratory plasticity and 
strengthens bicuculline- and/or saclofen-sensitive GABAA/B contributions to the central 
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response to hypercapnia far into adult life (at least to P65). Lastly, I show that IHc-pre-
treatment induces plasticity, sufficient to overcome disruption of ketanserin-sensitive 
mechanisms, regardless of the developmental period in which the IHc-pretreatment was 
administered. This indicates that there is no critical period for IHc-induced plasticity.  
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Figure 1.1 Brainstem respiratory-related regions. Neuroanatomy of the brainstem 
respiratory network arranged from the rostral pons to the caudal medulla. Horizontal 
from above (a) and parasagittal (b) views of the rat brainstem showing locations of the 
main groups of respiratory neurons in the mammalian central nervous system. Predomi-
nant locations of inspiratory, expiratory, tonic and respiratory-modulated (phasic) inter-
neurons are indicated in (b). Other abbreviations: AP, area postrema; cVRG, caudal ven-
tral respiratory group; med raphé, medullary raphé; Nad, nucleus ambiguous, dorsal divi-
sion; Pn, ventral pontine nucleus; rVRG, rostral ventral respiratory group; SO, superior 
olivary complex; V, motor nucleus of the trigeminal nerve; XII, hypoglossal motor nucleus. 
Modified from Smith et al., 2013. 
 
 
(a) (b) 
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Figure 1.2 Vital brainstem networks for breathing. Schematic representation of 
brainstem regions and microcircuits involved in respiratory rhythm generation. The pre-
Bötzinger complex (pre-BötC) and Bötzinger complex (BötC) are major components of the 
ventral respiratory column (VRC) generating multiple respiratory patterns as described in 
the text. This highly simplified diagram incorporates both excitatory and inhibitory re-
gions, as well as the interaction between them. Neurons within the pre-BötC, BötC, rostral 
ventral respiratory group (rVRG) and caudal ventral respiratory group (cVRG) receive 
tonic, phasic or rhythmic excitatory drive from the pontine, dorsal respiratory group 
(DRG), retrotrapezoid nucleus/parafacial respiratory group (RTN/pFRG) and raphé com-
partments. Drives from the latter two compartments are regulated in part by blood or 
brain CO2 levels (chemoreception). Modified from Smith et al., 2013. 
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Figure 1.3 Chemosensitive serotonergic neurons are closely associated with large 
medullary arteries. (a): Serotonergic neurons (green and yellow) in the medullary raphé 
are closely associated with the basilar artery (B) and its main midline branches (red) as 
indicated by confocal imaging after immunohistochemistry for tryptophan hydroxylase. 
(b): Serotonergic neurons in the raphé pallidus also appear to be in close association with 
a dense plexus of arteries. (c): A dendrite of a serotonergic raphé neuron (arrows) follows 
the wall of a large midline artery, and comes within 0.5 μM of the lumen (L) as shown by 
(a) 
(b) (d) 
(c) 
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electron microscopy. (d): Serotonergic neurons on the ventrolateral surface of the me-
dulla are also associated with large arteries. P, pyramidal tract. Scale bars 200 μm in (a) 
and (d), 50 μm in (b), and 1 μm in (c). Modified from Richerson, 2004. 
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Figure 1.4 “Push-pull” model of raphé contributions to the central response to hy-
percapnia. The complex organization of central CO2 chemoreception affords the potential 
for considerable plasticity, allowing for homeostatic regulation despite dysfunctional 
mechanisms, injury or disease. CO2 not only activates excitatory 5-HT neurons in the me-
dullary raphé, which are known to participate in respiratory control, but also deactivates 
inhibitory GABA neurons in this same region. This CO2-mediated deactivation of the in-
hibitory GABA raphé pathway causes disinhibition, and resultant stimulation of breathing. 
Thus, the excitatory 5-HT and inhibitory GABA pathways are thought to behave in a "push-
pull" manner to modulate ventilation (VE) via activity of central rhythm generators (CRG) 
and motor neuron pools (MNP).  
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Figure 1.5 Triple Risk Model of the Sudden Infant Death Syndrome. According to this 
model, SIDS results when three factors simultaneously influence an infant: (a) an under-
lying vulnerability in the infant, (b) a critical developmental period and (c) an exogenous 
stressor, e.g., prone sleep position. In the context of the Triple Risk Model, the risk factors 
for SIDS can be divided into extrinsic and intrinsic categories. Extrinsic risk factors are ac-
quired physical stressors related to the circumstances of death, e.g., prone sleep position. 
Such exogenous stressors are postulated to induce asphyxia, hypercapnia and hypoxia. 
Intrinsic risk factors, however, are associated with the underlying vulnerability/abnormal-
ity in the infant and increase the likelihood of SIDS by exacerbating this abnormality. 
Adapted from Filiano and Kinney, 1994. 
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Figure 1.6 Activity-dependent plasticity. Plasticity is indicated by the red color. Syn-
aptic plasticity may be induced by neuromodulators (neuromodulator-induced plasticity), 
which activate intracellular signaling molecules (red), secondarily altering the strength of 
other (glutamatergic or GABAergic) synaptic inputs. Activity-dependent plasticity may 
arise from coincident pre- and postsynaptic activity, thereby altering presynaptic trans-
mitter release or postsynaptic receptor function in a manner similar to long-term poten-
tiation and long-term depression. Silent synapses (anatomically present but functionally 
ineffective) may be revealed by neuromodulator or activity-dependent mechanisms. 
Modified from Mitchell and Johnson, 2003. 
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Figure 1.7 Morphological changes underlying respiratory plasticity. The struc-
ture/function of neuromodulatory systems may change, increasing or decreasing the ca-
pacity for neuromodulation. Neuron properties may change, such as size and shape of the 
dendrites or somata and density of dendritic spines. In addition, new synapses may be 
formed or pruned. Modified from Mitchell and Johnson, 2003. 
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Figure 1.8 In situ unanesthetized perfused decerebrate brainstem preparation for 
assessment of central chemosensitivity. Central CO2 chemosensitivity was assessed using 
an in situ unanesthetized perfused decerebrate brainstem preparation (Paton, 1996). 
Preparations were maintained with perfusate equilibrated with 5 % CO2 in 95 % O2, and 
exposed to a 5-min 4 %-hypercapnic challenge (9 % CO2, balance O2). Phrenic neurograms 
were recorded and analyzed for burst frequency, amplitude and the multiple (neural mi-
nute ventilation; NVE) to illustrate neural equivalents of breathing and sensitivity to the 
hypercapnic challenge. 
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Chapter 2 
Intermittent hypercapnia enhances CO2 responsiveness and overcomes ketanserin-in-
duced dysfunction1 
2.1 Abstract 
Abnormal homeostatic responses to increased levels of CO2 are associated with numer-
ous dangerous or life-threatening disorders. We tested the hypothesis that postnatal ex-
posure to mild intermittent hypercapnia (IHc) induces respiratory plasticity. Rats were 
exposed to an IHc protocol (or air control) for 5 days beginning at P12. We subsequently 
assessed CO2 responsiveness using the in situ perfused brainstem preparation. Hypercap-
nia responses were determined in air or IHc-pretreated groups, both with and without 
pharmacological manipulation. Results confirmed CO2 chemoresponsiveness of the ex-
perimental preparation and that ketanserin abolished this responsiveness in control 
groups. IHc-pretreatment enhanced CO2 responsiveness.  IHc-pretreatment maintained 
CO2 responsiveness despite ketanserin treatment.  We conclude that ketanserin-sensitive 
mechanisms are normally necessary for CO2 chemoresponsiveness, that IHc-pretreat-
ment enhances CO2 responsiveness and that IHc-pretreatment induces non-ketanserin-
sensitive contributions to CO2 chemoresponsiveness. CO2 responsiveness following IHc-
pretreatment was absent if ketanserin was combined with bicuculline and saclofen, indi-
cating that plasticity may depend on bicuculline- and/or saclofen-sensitive mechanisms. 
 
1 Mosher BP, Taylor BE, Harris MB. Intermittent hypercapnia enhances CO2 responsiveness and overcomes 
ketanserin-induced dysfunction. Respir. Physiol. Neurobiol., in review. 
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We propose that IHc-induced plasticity could reduce the severity of reflex dysfunctions 
underlying pathologies associated with abnormal responses to hypercapnic conditions, 
possibly including the Sudden Infant Death Syndrome (SIDS) 
 
2.2 Introduction 
The brain’s ability to detect and respond to changes in CO2/pH (central CO2 chemosensi-
tivity) is a fundamental homeostatic process and essential for life. Specific brainstem neu-
ron types responsible for central chemosensitivity in vivo are poorly understood and are 
the topic of ardent debate (Guyenet et al., 2005; Guyenet, 2008; Nattie and Li, 2009; 
Richerson et al., 2001). Central CO2 chemoreception is likely best described as a complex 
system function that involves a limited but varied group of neuron types, brainstem sites 
and multiple neurotransmitter mechanisms (Feldman et al., 2003; Nattie, 2009; Nattie 
and Li, 2009; Putnam et al., 2004). It may be that different mechanisms contribute to 
sensitivity under different conditions. Organization of chemosensitivity as a system func-
tion affords the potential for considerable plasticity. Not only could a specific mechanism 
play a differential role in overall system sensitivity under specific conditions, the involve-
ment of multiple mechanisms may allow homeostatic regulation despite partial dysfunc-
tion, injury or disease (Feldman et al., 2003). Thus, if one reflex mechanism is dysfunc-
tional, alternative mechanisms may facilitate an appropriate response.  
Medullary raphé neurons contribute to chemoresponsiveness. Located within the 
raphé are at least two neuronal subsets documented to possess intrinsic chemosensitivity 
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in vitro (Corcoran et al., 2009; Richerson, 2004; Richerson et al., 2005; Wang et al., 1998; 
Wu et al., 2008); acidosis-stimulated, serotonin(5-HT)-synthesizing neurons and acidosis-
inhibited, γ-aminobutyric acid(GABA)-synthesizing neurons. We have developed a model 
describing raphé contributions to central chemosensitivity wherein both 5-HT and GABA 
mechanisms modulate ventilation to maintain tissue CO2/pH through synaptic activation 
and disinhibition, respectively (Corcoran et al., 2008; Richerson, 1995). We have demon-
strated that these cell types retain chemosensitivity in the intact and unanesthetized 
brainstem (Corcoran et al., 2008, 2013; Iceman et al., 2013). Hypercapnia stimulates 5-HT 
neurons, contributing to excitation of ventilation. Hypercapnia also inhibits normally in-
hibitory GABA neurons, stimulating ventilation through disinhibition (Hodges et al., 2004). 
Importantly, chemosensitivity must regulate ventilation in the hypocapnic range as well. 
We propose that hypocapnia/alkalosis not only inhibits 5-HT neurons reducing ventilatory 
stimulation, but also stimulates inhibitory GABA neurons to inhibit ventilation.  So, alt-
hough the ventilatory homeostatic response to hypercapnia is normally primarily medi-
ated by 5-HT-synthesizing neurons (Corcoran et al., 2008), it may be possible that 
strengthening alternative mechanistic pathways could preserve responsiveness to a hy-
percapnic challenge despite a dysfunction in 5-HT mechanisms.  
Ventilatory CO2 chemoresponsiveness is abolished by acute disruption of 5-HT 
mechanisms (Corcoran et al., 2013). However, genetically modified mice chronically lack-
ing 5-HT neurons retain partial CO2 responsiveness (Hodges et al., 2008). We speculate 
that although 5-HT mechanisms are normally critical, plasticity in response to a chronic 
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absence of 5-HT neurons can accommodate appropriate CO2 chemoresponsiveness by in-
ducing alternative mechanisms. We propose that plasticity could be induced to precondi-
tion the system and enhance other chemosensory mechanisms. We tested the hypothesis 
that preconditioning with intermittent hypercapnia (IHc) during postnatal development 
induces plasticity, and that this plasticity compensates for the loss of normally critical 5-
HT mechanisms. Furthermore, based on our model of 5-HT- and GABA-mediated contri-
butions to the central CO2 response, we hypothesized that plasticity results from en-
hancement of GABA-mediated mechanisms. 
Abnormalities in 5-HT brainstem nuclei are associated with infant vulnerability to 
the Sudden Infant Death Syndrome (SIDS), and that vulnerability may result in part from 
CO2 chemoresponsive dysfunction (Cummings et al., 2009; Duncan et al., 2010; Hodges 
and Richerson, 2010; Kinney et al., 2009; Paterson et al., 2006; Richerson, 2004). If in-
duced plasticity is sufficient to overcome or reverse ventilatory CO2 chemoresponsive dys-
functions similar to those thought to contribute to SIDS, then interventions that induce 
plasticity could be therapeutic in augmenting CO2 chemoresponsiveness in vulnerable in-
dividuals. 
 
2.3 Methods 
Experimental groups: All experiments were done in accordance with the guidelines of the 
“Guide for the Care and Use of Laboratory Animals” of the National Institutes of Health 
and were approved by the University of Alaska Fairbanks (UAF) Institutional Animal Care 
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and Use Committees. Nineteen naïve rat dams received normal rat chow and water ad 
libitum, and were bred with 19 males. Sprague-Dawley rats were used in all experiments 
(Simonson Laboratories). Resulting pups also received food and water ad libitum and 
were housed and maintained in the UAF Animal Care Facility on a 12 h light/dark cycle, at 
a room temperature of 21 °C. A total of 112 animals from both sexes were used in these 
studies. 
Gas pretreatments: Rat pups were exposed to intermittent hypercapnia (IHc; 8 
consecutive cycles of 5 min 5 % CO2: balance air, followed by 10 min air) or constant 
normocapnia as a control (Nc; Type 1-Grade D air only, as a treatment sham) each day for 
5 consecutive days beginning at post-natal day 12 (P12). Entire litters were randomly as-
signed to either IHc- or Nc-pretreatment. Because related litter-mates, rather than ran-
domly assigned individuals, were used as experimental subjects, multiple litters (2 to 5) 
received each combination of gas and pharmacological treatments. During gas treat-
ments, dams were separated from pups and the home cage was transported to a proce-
dure room adjacent to the animal holding area. Cages were fitted with an airtight lid with 
a gas inflow and outflow. In this manner, litters (ranging from 3 to 15 pups) were exposed 
to room temperature inlet gas, supplied at 10 l/min through a countercurrent heat ex-
changer. The gas outlet was connected to 1 m of 5.5 mm internal diameter tubing to pre-
vent room air infiltration without creating substantial positive pressure within the cham-
ber. For intermittent gas exposure, a programmable digital timer and solenoid valve au-
tomatically switched inlet gases between the two sources. This apparatus produced a 10-
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min period of normocapnia followed by 8 repeated cycles of 5-min hypercapnia (or 
normocapnia in controls) and 10-min normocapnia. Valve cycling was monitored using a 
computerized data acquisition system (LabChart 7, ADInstruments). Pilot studies indi-
cated that CO2 levels in the enclosure equilibrated with inlet gas concentrations within 90 
s. Chamber gas was not monitored during these treatments. After this exposure protocol, 
cages were removed from the enclosure, dams were returned to pups in the home cage 
and cages were returned to the adjacent housing facility. In no cases did pup abandon-
ment occur following these brief maternal separations, and patterns and durations of ma-
ternal separation were equal between IHc and Nc treatment groups. Exposure protocols 
were repeated on 5 consecutive days, at approximately the same time each day. 
In situ assessment of CO2 chemoresponsiveness: At least 7 days following IHc- or 
Nc-pretreatments, hypercapnic ventilatory responsiveness was assessed using the in situ 
arterially perfused brainstem preparation as previously described (Corcoran et al., 2013; 
Toppin et al., 2007, after Paton, 1996). Briefly, animals were anesthetized with isoflurane 
(5 %, vaporized in 100 % O2) and pretreated with heparin sodium (500 units, I.P.). Animals 
were bisected subdiaphragmatically and submerged in an ice-chilled artificial cerebral spi-
nal fluid (aCSF) containing (mM in H2O): MgSO4·7H2O, 1; NaH2PO4H2O, 1.25; KCl, 4; Na-
HCO3, 24; NaCl, 115; D-glucose, 10; CaCl2·2H2O, 2). The forebrain rostral to the colliculi 
was removed by aspiration, and fur, skin and viscera were removed. The diaphragm was 
separated from the body wall with care taken to ensure integrity of the phrenic nerve. 
The preparation was moved to the recording station where the descending aorta was 
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cannulated using a double-lumen catheter (Ø 1.25 mm, Braintree Scientific) and perfused 
retrogradely from a reservoir containing 350 ml aCSF (with 13 g/l ficoll 70, Sigma, added 
as an osmotic agent). The perfusate was first equilibrated with 95 % O2-5 % CO2 
(normocapnia, pH 7.4, PCO2 of 33 mmHg). Equilibration mixtures were produced from O2 
and CO2 using a precision gas mixer (GSM3, CWE) and verified with a CO2 analyzer (CD-
3A, Applied Electrochemistry). Normocapnic (baseline) conditions approximated 
normocapnic plasma in vivo.  Lacking hemoglobin, solution hyperoxia (PO2 ≈ 600 mmHg) 
was necessary to maintain O2 content sufficient to meet tissue metabolic demands. This 
unavoidable hyperoxia was constant under all conditions. Perfusate was warmed to 32 
°C, and circulated through a bubble trap and particle filters (25 μm, 45 μm; Millipore) prior 
to entering the aorta. Perfusate passing through the animal was collected and recycled to 
the reservoir. The neuromuscular blocker gallamine triethiodide (20 mg/l), and the vaso-
constricting hormone vasopressin (5 μM) were added to the perfusate. The aortic perfu-
sion pressure was adjusted to 70-80 mmHg using an adjustable perfusate bypass valve 
and a bolus of sodium cyanide (50 μl 0.1 % solution) was injected into the perfusate line 
to transiently stimulate peripheral chemoreceptors (Dutschmann et al., 2000). After par-
tial pulmonectomy, the phrenic nerve was exposed and aspirated into a glass capillary 
suction electrode pulled to a diameter that ensured adequate seal on the nerve.  
The signal was amplified (×10,000; DAM50, WPI) and filtered (band-pass 300 Hz – 
1 kHz). Using a computerized data acquisition system (Powerlab, ADInstruments), data 
were digitized at 1 k Samples/s and digitally integrated through full wave rectification and 
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50 ms moving average on a duplicate channel. Phrenic burst frequency (f, bursts/min) was 
determined by counting the number of phrenic bursts occurring during 60 s of normocap-
nia immediately preceding the gas challenge, the final 60 s of hypercapnia, and 60 s during 
normocapnic recovery 5 min after a return to baseline. Phrenic burst amplitude was de-
rived from the mean integrated peak height of all bursts within these 60 s periods, ex-
pressed in arbitrary units within each preparation and as a proportional change within a 
preparation in response to the gas challenge. Neural minute ventilation (NVE) was calcu-
lated as the product of burst frequency and amplitude, again expressed in arbitrary units 
and as a proportional change with treatment (Eldridge, 1971). 
Gas Challenges: Preparations were maintained on normocapnic perfusate for at 
least 1 h. For the gas challenge, gas equilibrating the perfusate was switched in sequence 
to 5-min periods of hypocapnia (96.5 % O2-3.5 % CO2; pH 7.5; PCO2 ≈ 23 mmHg) followed 
by 5-min periods of hypercapnia (91 % O2-9 % CO2; pH 7.2; PCO2 ≈ 60 mmHg) and subse-
quently returned to baseline normocapnia.  The hypercapnic challenge conditions approx-
imated those occurring during a 4 % increase in inspired CO2. 
Pharmacological challenges: Preparations were tested either without further 
pharmacological manipulation, or with the addition of specific antagonists to disrupt par-
ticular neurotransmitter signaling mechanisms. Pharmacological agents were added after 
the 60-min normocapnic period, which was maintained for an additional 10-min prior to 
gas challenge. In one series, the 5-HT2 receptor antagonist ketanserin tartrate (5 μM, 
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Sigma) was administered to determine how subsequent responsiveness to CO2 was af-
fected by impairment of ketanserin-sensitive processes. We have previously shown that 
a ketanserin-sensitive mechanism is important for CO2 chemoresponsiveness in this sys-
tem (Corcoran et al., 2013). In a second series, the GABAA and GABAB receptor antagonists 
bicuculline (20 μM, Sigma) and saclofen (20 μM, abcam) were administered to determine 
to what degree the hypercapnic ventilatory response was due to bicuculline- and saclo-
fen-sensitive mechanisms. In a third series, a combination of ketanserin and bicuculline 
and saclofen was administered to assess the influence of combined antagonism of ketan-
serin-sensitive and bicuculline- and saclofen-sensitive processes on hypercapnic re-
sponse.  
Data and statistical analyses:  Ventilatory parameters were quantified from the 
integrated neurograms. Frequency (f; the number of bursts per unit time), amplitude (the 
mean integrated peak amplitude of bursts), and a neural correlate of minute ventilation 
(NVE; frequency·amplitude) were calculated from periods of normocapnia or hypercap-
nia. Hypercapnic responsiveness was determined from ventilatory parameters recorded 
during baseline normocapnia and hypercapnia. This was quantified by deriving a relative 
hypercapnic response, calculated by expressing the difference in parameter values be-
tween normocapnia and hypercapnia, normalized as a percentage relative to values oc-
curring with normocapnia prior to gas challenge (responsiveness = [value during hyper-
capnia – value during normocapnia] / value during normocapnia). 
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Data Parsing: We and others have demonstrated that the in situ rat brainstem 
preparation exhibits clear responsiveness to hypercapnia and provides an appropriate 
model for the study of mechanisms contributing to chemosensitivity (Corcoran et al., 
2013; Day and Wilson, 2007; Iceman et al., 2013; Toppin et al., 2007). These prior studies 
have illustrated that the response is most clearly manifest in changes in burst frequency 
and the index of minute ventilation, NVE. Our pilot investigations suggested the possibility 
that preparations exhibiting a relatively high initial burst frequency have a lower apparent 
responsiveness to hypercapnia, which suggests a frequency limitation. The present study 
was designed to investigate mechanisms contributing to CO2 responsiveness, necessitat-
ing a focus on responsive preparations free of potential confounding factors.  
To remove the potential confounding influence of dampened CO2 chemorespon-
siveness in preparations with elevated baseline burst frequencies, we subjected the data 
set to the following parsing protocol. In preparations exposed to neither pharmacological 
manipulation nor IHc-pretreatment, we plotted the relationship between hypercapnic re-
sponsiveness and initial burst frequency and determined a linear regression (P < 0.001; R2 
= 0.74) described by the equation: hypercapnic responsiveness (HcR) = 192 – 3.45 (initial 
frequency). The highest responsiveness observed in any of these preparations was an 84.6 
% increase. From this regression, we determined the initial frequency associated with the 
half-maximum CO2 responsiveness. We then used this value as a threshold to identify 
preparations in which high initial burst frequency could confound expression of CO2 
chemoresponsiveness. Preparations having a normocapnic initial burst frequency above 
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this threshold were omitted from all portions of analysis. When so parsed, 17 of 112 prep-
arations (15 %) were removed from analyses; a total of 95 preparations contributed to 
the analyzed data set. 
One-way repeated-measures analysis of variance (RM-ANOVA) was used to com-
pare parameter values before and during hypercapnia for each drug treatment (no drugs; 
ketanserin alone; bicuculline + saclofen; ketanserin + bicuculline + saclofen), which quan-
tified hypercapnic responsiveness for ventilatory parameters under each drug treatment. 
One-way ANOVA was used to compare the effect of drug treatment on the relative hy-
percapnic response in each parameter. Values reported in the text are mean ± standard 
error. To compare the mean hypercapnic responsiveness for each parameter between 
groups, a Tukey post-hoc analysis was used following a significant ANOVA. 
 
2.4 Results 
Burst discharge recordings:  All our recorded phrenic neurograms displayed a “eupneic” 
pattern (Fig. 2.1) characteristic of this preparation (Eldridge, 1971; St.-John and Paton, 
2000), and displayed this pattern throughout normocapnia, hypercapnia and recovery 
from normocapnia, and drug treatment. Preparations without pharmacological manipu-
lation derived from pups that were Nc-pretreated (sham air exposures), had a mean 
normocapnic burst frequency of 20.7 ± 1.26 bursts/min.  
Response to hypercapnia:  In preparations derived from pups pretreated with Nc, 
mean f and NVE increased during hypercapnia by 22 ± 5.0 % (Fig. 2.2) and 27 ± 14 % (Fig. 
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2.3), respectively. One-way RM-ANOVA indicated that these hypercapnia-induced 
changes were significant (P < 0.001 for f; P < 0.05 for NVE). No significant responsiveness 
was resolved for burst amplitude alone (P = 0.62). Nc-pretreated preparations that re-
ceived ketanserin had no significant response to hypercapnia (non-significant increases in 
f = 3.4 ± 7.5 %, P = 0.61, Fig. 2.2; NVE = 5.6 ± 11.0 %, P = 0.58; Fig. 2.3; amplitude = -0.3 ± 
6.0 %, P = 0.83, Fig. 2.4). Statistically, the absent responsiveness with ketanserin was dif-
ferent from the responsiveness present without ketanserin treatment in Nc-pretreated 
preparations (frequency, P < 0.05, Fig. 2.2). In preparations derived from pups pretreated 
with Nc, and treated with bicuculline and saclofen, f and NVE increased during hypercap-
nia by 31 ± 10 % (P < 0.05; Fig. 2.2) and 61 ± 10 % (P < 0.05; Fig. 2.3), but did not increase 
amplitude 24 ± 9.8 (P = 0.11; Fig. 2.4) respectively. The hypercapnic responsiveness of 
preparations derived from Nc-pretreated pups with bicuculline and saclofen was no dif-
ferent than the responsiveness for preparations derived from pups pretreated with Nc 
that did not receive pharmacological manipulation (P = 0.43 for f; P = 0.28 for NVE; P = 
0.62 for amplitude). As ketanserin treatment alone abolished CO2 chemoresponsiveness 
in Nc-pretreated preparations, bicuculline and saclofen were not co-applied with ketan-
serin. 
In preparations from pups pretreated with IHc, mean f and NVE increased during 
hypercapnia (increases of 38 ± 11 %, P < 0.001, Fig. 2.2; and 130 ± 58 %, P < 0.001, Fig. 
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2.3; respectively), but burst amplitude did not (P = 0.68; Fig 2.4). Hypercapnic responsive-
ness as measured by NVE was significantly greater in preparations from IHc-pretreated 
pups than those from Nc-pretreated pups (P ≤ 0.05, Fig. 2.3). 
Unlike in Nc-pretreated pups, in preparations derived from pups pretreated with 
IHc, f and NVE increased in response to hypercapnia under ketanserin treatment (f = 28 ± 
3 %, P < 0.001, Fig. 2.2; NVE: 29 ± 5 %, P < 0.001, Fig. 2.3). This responsiveness was less 
than that of preparations derived from IHc-pretreated pups without ketanserin treatment 
(NVE, P < 0.05, Fig. 2.3) but was no different than that of Nc-pretreated preparations 
without ketanserin (frequency, P = 0.25; NVE, P = 0.90). 
When bicuculline, saclofen and ketanserin were co-applied in preparations de-
rived from IHc-pretreated pups, none of the parameters (frequency, NVE or amplitude) 
indicated a response to hypercapnia. This responsiveness was less than the responsive-
ness present subsequent to ketanserin treatment alone in IHc-pretreated preparations 
(frequency, P < 0.001, Fig. 2.2; NVE: P < 0.01, Fig. 2.3), and equal to that of Nc-pretreated 
preparations treated with ketanserin alone (frequency, P = 0.28, Fig. 2.2; NVE: P = 0.47, 
Fig. 2.3). Hypercapnic challenge failed to increase phrenic burst amplitude in any group. 
Additionally, there was no difference between the burst amplitude responses to hyper-
capnia between groups (Fig. 2.4). 
The in situ preparation is responsive to hypercapnia under control (Nc-pretreated) 
conditions, and this response is dependent on ketanserin-sensitive mechanisms, but not 
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on bicuculline- and saclofen-sensitive mechanisms. The hypercapnic response was en-
hanced by IHc-pretreatment, and a portion of the hypercapnic response was retained de-
spite removal of ketanserin-sensitive mechanisms. Retained chemoresponsiveness was 
dependent on bicuculline- and/or saclofen-sensitive mechanisms. 
 
2.5  Discussion 
Our study assessed the effect of pretreatment with intermittent hypercapnia during post-
natal development on CO2 chemoresponsiveness. We tested the hypothesis that postna-
tal IHc-pretreatment induces respiratory plasticity. Specifically, we assessed if IHc-pre-
treatment would enhance hypercapnic responsiveness, and if this enhancement would 
compensate for the compromised responses induced by ketanserin treatment. Further-
more, we tested the hypothesis that bicuculline- and saclofen-sensitive mechanisms con-
tribute to this plasticity. 
Our results confirm that the rat in situ perfused brainstem preparation does ex-
hibit a CO2 response (Corcoran et al., 2013; Day and Wilson, 2007). We also confirmed 
previous findings that ketanserin-sensitive mechanisms are critical to CO2 chemorespon-
siveness (Corcoran et al., 2013), as ketanserin treatment alone abolishes CO2 responsive-
ness in preparations derived from Nc-pretreated rats. The primary influence of ketan-
serin, in respiratory control mechanisms, is as a post-synaptic 5-HT2 receptor antagonist 
(Awouters, 1985, Corcoran et al., 2013). Previous studies investigating CO2 chemorespon-
siveness using the in situ preparation have used ketanserin to determine the role of post-
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synaptic 5-HT2 receptors (Corcoran et al., 2013).  As ketanserin not only blocks 5-HT2 re-
ceptors but also alpha-1 adrenergic (Hoyer et al., 1987) and histamine H1 receptors (Bor-
roto-Escuela et al., 2014), as well as 5-HT7 and dopamine D1 and D2 receptors with limited 
affinity (Shen et al., 1993; Wouters et al., 1985), Corcoran et al. (2013) acknowledge that 
the disrupted response to the hypercapnic challenge may have resulted from a depend-
ence of CO2 chemoresponsiveness on alpha-1 adrenergic, histamine H1 or 5-HT7 receptor 
activation. However, the primary outcome of ketanserin administration was similar to 
that resulting from the administration of the 5-HT1A receptor agonist (R)-(+)-8-hydroxy-
2(di-n-propylamino) tetralin (8-OH-DPAT; Corcoran et al., 2013) which is commonly used 
in respiratory studies to inhibit 5-HT neuron transmitter release via activation of hyperpo-
larizing 5-HT1A autoreceptors (St. John and Paton, 2000). In addition, a similar outcome to 
ketanserin was also observed following application of the mixed 5-HT1,2 receptor antago-
nist methysergide (Harris et al., 2003). Thus, the most likely conclusion is that elimination 
of the hypercapnic ventilatory response by ketanserin was due to disruption of 5-HT pro-
cesses, and that ketanserin-sensitive influences illustrate 5-HT contributions to hypercap-
nic responsiveness. We attribute our observation of ketanserin-sensitive CO2 
chemoresponsiveness to suggest that 5-HT neurotransmission is critical for CO2 chemo-
sensitivity in this experimental system (Corcoran et al., 2013). 
Despite this apparent critical role of 5-HT mechanisms, central CO2 chemosensitiv-
ity is a complex system function that involves multiple neuron types, brainstem sites, and 
neurotransmitter mechanisms (Feldman et al., 2003; Nattie, 2009; Nattie and Li, 2009; 
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Putnam et al., 2004). Diversity and redundancy in such a system function allows for plas-
ticity and homeostatic regulation despite dysfunction in any one pathway (Feldman et al., 
2003). 
We illustrate that plasticity induced through IHc-pretreatment can overcome the 
CO2 chemoresponse impairment normally associated with disruption of ketanserin-sensi-
tive mechanisms. We propose that chemosensory plasticity can be induced with precon-
ditioning to enhance multiple chemosensory mechanisms, specifically facilitating the re-
cruitment of non-ketanserin-sensitive mechanisms to preserve CO2 chemoresponsiveness 
even under circumstances in which ketanserin would normally eliminate the hypercapnic 
response. 
Under normocapnic conditions, neuroventilatory parameters in preparations pre-
treated with IHc were comparable to those of preparations derived from Nc-pretreated 
pups. Preconditioning with IHc, however, greatly augmented CO2 chemoresponsiveness. 
When compared to Nc-pretreated preparations, CO2 chemoresponsiveness was increased 
73 % for frequency and 381 % for NVE, in IHc-pretreated preparations. 
Ours is the first reported observation that IHc-pretreatment can influence subse-
quent CO2 chemoresponsiveness. In these experiments, IHc-pretreatments were initiated 
on P12 and continued daily through P16. Protocols were designed to administer cycles of 
mild hypercapnia to pups, without altering maternal conditions and while limiting mater-
nal separation. This developmental period was chosen to follow the apparent critical pe-
riod proximal to P12 where rat CO2 chemosensitivity is altered (Putnam et al., 2005; 
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Wong-Riley and Liu, 2005, 2008), and the developmental period beyond which CO2 
chemosensitive 5-HT neurons have been identified in vitro (Wang and Richerson, 1999). 
Prior attempts to influence hypercapnic responsiveness showed no influence when a 
comparable IHc protocol was conducted between P7 and P14 (Steggerda et al., 2009). It 
is likely that the developmental timing and/or nature of the IHc stimulus influences re-
sultant plasticity. 
We attribute the lack of hypercapnic response after application of ketanserin to 
disruption of normally critical 5-HT mechanism. We attribute the retention of relatively 
normal CO2 chemoresponsiveness, overcoming the expected ketanserin-mediated abol-
ishment of CO2 chemoresponsiveness, to plasticity imparted by the IHc-pretreatment. We 
conclude that IHc-pretreatment induced a ketanserin-insensitive mechanism not obvi-
ously critical to hypercapnic responsiveness. This plasticity appears sufficient to overcome 
what is normally a complete lack of hypercapnic responsiveness associated with ketan-
serin administration. 
The organization of CO2 chemosensitivity as a system function grants the potential 
for considerable plasticity. Not only could a particular mechanism play a differential role 
in overall system sensitivity under particular conditions, the involvement of multiple 
mechanisms may allow homeostatic regulation despite partial dysfunction, injury, or dis-
ease (Feldman et al., 2003). Thus, if one reflex mechanism is dysfunctional, alternative 
mechanisms may accommodate an appropriate response. Our observations indicate that 
plasticity initiated with IHc-pretreatment resulted in CO2 chemoresponsiveness mediated 
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by mechanisms other than the ketanserin-sensitive mechanisms normally critical for CO2 
responsiveness. As such, we investigated whether IHc-induced plasticity was enhancing 
an alternate non-ketanserin-sensitive mechanism. 
We have suggested that interactions between chemosensory mechanisms medi-
ated either by 5-HT- or GABA-synthesizing neurons contribute to CO2 chemosensitivity 
(Iceman et al., 2010; Richerson et al., 2001, 2005). As such, we predicted that the ketan-
serin-insensitive chemoresponsiveness induced by IHc-pretreatment was due to an en-
hancement of GABA-mediated mechanisms (Corcoran et al., 2008; Richerson, 1995). To 
broadly investigate the contribution of GABA mechanisms, we tested the combined influ-
ences of GABAA and GABAB receptor antagonists bicuculline and saclofen. Bicuculline and 
saclofen treatment had no influence on CO2 chemoresponsiveness in Nc-pretreated prep-
arations, indicating that bicuculline- and saclofen-sensitive GABAA/B receptor-mediated 
processes are not obviously critical to CO2 chemoresponsiveness under normal condi-
tions. Bicuculline- and saclofen-sensitive processes may not normally be necessary, and 
other processes may be sufficient, for hypercapnic responsiveness. 
We assessed whether or not the ketanserin-insensitive CO2 responsiveness pre-
sent in IHc-pretreated preparations was mediated by bicuculline/saclofen-sensitive 
mechanisms. Although IHc-pretreated preparations maintained CO2 chemoresponsive-
ness when treated with ketanserin alone, CO2 responsiveness was absent in preparations 
with combined ketanserin, bicuculline and saclofen treatment. These results suggest that 
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the plasticity induced by IHc-pretreatment, responsible for ketanserin-insensitive CO2 re-
sponsiveness, was induced through bicuculline- and/or saclofen-sensitive processes not 
normally critical for CO2 chemoresponsiveness. 
 
2.6 Conclusion 
Our findings are consistent with considerations of central CO2 chemosensitivity as a sys-
tem function involving multiple neuron types and neurotransmitter mechanisms. We pro-
pose that 5-HT and GABA mechanisms contribute to CO2 chemosensitivity. We confirm 
the finding that, in otherwise untreated preparations, ketanserin-sensitive mechanisms 
are important for the ventilatory response to CO2. We show that IHc-pretreatment in-
duces plasticity such that CO2 chemoresponsiveness is maintained despite removal of oth-
erwise critical ketanserin-sensitive mechanisms, and that this plasticity depends on bicu-
culline- and/or saclofen-sensitive mechanisms that are not obviously critical to CO2 
chemoresponsiveness under normal conditions. 
Abnormal homeostatic responses to increased levels of CO2 are associated with 
numerous dangerous or life-threatening disorders. Serotonin dysfunction likely contrib-
utes to a number of pathologies, including the Sudden Infant Death Syndrome (SIDS), by 
compromising homeostatic reflexes such as hypercapnic chemoresponsiveness (Kinney 
et al., 2009). It may be that IHc-induced plasticity to enhance the contributions of other 
neurotransmitter pathways to CO2 chemoresponsiveness could enhance homeostatic re-
flex efficacy and potentially reduce vulnerabilities to conditions such as SIDS. A number 
68 
of critical factors remain unknown. These include: identification of the exact mechanisms 
underlying bicuculline- and saclofen-sensitive chemosensory plasticity; changes in ketan-
serin-sensitive mechanisms with IHc-pretreatment; the degree to which IHc-pretreat-
ment can overcome chronic chemosensory dysfunctions similar to those associated with 
various pathologies; potential developmental sensitivities to IHc-induced plasticity; and 
the longevity of this plasticity. The clear potential to induce chemosensory plasticity, how-
ever, provides possible targets for therapeutic intervention to reverse or offset 
chemosensory dysfunction. 
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2.8 Figures 
See below where figures are displayed on full pages. 
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Figure 2.1 Eupneic phrenic ventilatory burst in situ. Typical eupneic integrated 
phrenic neurogram recording with ventilatory bursts representing the neural correlate of 
ventilation (Eldridge, 1971; St.-John and Paton, 2000). When the in situ preparation was 
exposed to perfusate containing 9 % CO2 (4 % hypercapnic challenge; bottom panel) there 
was an increase in both frequency and NVE (frequency*amplitude) of ventilatory events 
compared to 5 % CO2 exposure (normocapnia; top panel). Both panels are representative 
records of the last minute of the indicated CO2 treatment. Tracings from a preparation 
derived from a pup that received Nc-pretreatment (sham treatment) and no pharmaco-
logical manipulations are shown. 
 
 
 
5 % CO2 
9 % CO2 
5 sec 
5 sec 
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Figure 2.2 Influence of IHc on frequency response to hypercapnia. Hypercapnia in-
creased ventilatory frequency, normalized to normocapnia, in preparations derived from 
Nc-pretreated pups without drugs (no fill bar, n = 20), those that were Nc-pretreated and 
received bicuculline (bic) and saclofen (sac, grey bar, n = 4), those that were IHc-pre-
treated and received no drugs (horizontal stripe bar, n = 16) and those that were IHc-
pretreated and received ketanserin (ket, vertical stripe bar, n = 27). Each bar represents 
mean ± SE. Significant increase from normocapnia to hypercapnia (one-way RM-ANOVA): 
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*P < 0.05, ***P < 0.001. Between groups comparison of difference in response to hyper-
capnia determined using one-way ANOVA: †P < 0.05, †††P < 0.001.  
 
 
 
 
 
 
 
 
 
78 
 
Figure 2.3 Influence of IHc on NVE response to hypercapnia. Hypercapnia increased 
ventilatory NVE, normalized to normocapnia, in preparations derived from pups that 
were Nc-pretreated and did not receive drugs (no fill bar), those that were Nc-pretreated 
and received bicuculline (bic) and saclofen (sac, grey bar), those that were IHc-pretreated 
and did not received drugs (horizontal stripe bar) and those that were IHc-pretreated and 
received ket (vertical stripe bar). Each bar represents mean ± SE. Significant increase from 
normocapnia to hypercapnia (one-way RM-ANOVA): *P < 0.05, ***P < 0.001. Between 
groups comparison of difference in response to hypercapnia determined using one-way 
ANOVA: †P ≤ 0.05, ††P < 0.01. 
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Figure 2.4 Influence of IHc on amplitude response to hypercapnia. Hypercapnia 
failed to increase phrenic burst amplitude. Each bar represents mean ± SE. There was no 
resolvable difference between groups, determined using one-way ANOVA. 
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Chapter 3 
Intermittent hypercapnia enhances CO2 responsiveness and overcomes dysfunction 
induced by dietary tryptophan deficiency 1 
3.1 Abstract 
Serotonin (5-HT) dysfunction is thought to enhance vulnerability to the Sudden Infant 
Death Syndrome (SIDS) by compromising critical homeostatic reflexes. Rat dams fed a 
tryptophan (Trp)-deficient diet produced pups with low brainstem tissue 5-HT and exhib-
ited a reduced ventilatory response to inspired CO2 in vivo (Penatti et al., 2011). We used 
an in situ perfused brainstem preparation derived from pups of dams fed either a control 
or Trp-deficient diet to test the hypothesis that developmental Trp deficiency alters cen-
tral CO2/pH chemoresponsiveness. We also investigated the efficacy of a previously de-
scribed intermittent hypercapnia (IHc) protocol (Mosher et al., in review) to reverse the 
dampened hypercapnic response induced by the dietary Trp restriction. Results indicate 
that the response to hypercapnia is decreased in preparations derived from animals main-
tained on the Trp-deficient diet. Additionally, for animals maintained on the Trp-deficient 
diet that were also pretreated with IHc, the reduced hypercapnic response was restored 
to levels comparable to control animals. We previously showed that IHc-pretreatment 
enhances the response to hypercapnia (Mosher et al., in review). These data further illus-
trate that dietary Trp restriction, likely resulting in decreased brainstem 5-HT, induces a 
 
1 Mosher BP, Taylor BE, Harris MB. Intermittent hypercapnia enhances CO2 responsiveness and overcomes 
dysfunction induced by dietary tryptophan deficiency. Prepared for publication in J. Appl. Physiol. 
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measurable reduction of the hypercapnic ventilatory response, and that IHc-pretreat-
ment of Trp-deficient pups restores CO2 responsiveness to that of control animals. Results 
may shed light on a possible intervention that could be used to enhance the central re-
sponse to hypercapnia under conditions in which it is impaired. 
 
3.2 Introduction 
The present study was conducted to provide insight into respiratory physiology and pa-
thologies thought to result from chemosensory dysfunction, such as the Sudden Infant 
Death Syndrome (SIDS). SIDS, the leading cause of infant mortality between the ages of 1 
month and 1 year, is defined as the sudden death of an infant that is unexplained after 
reviewing clinical history and cannot be explained after a thorough death scene investi-
gation and post-mortem examination (Moon et al., 2007; Willinger et al., 1991). A consid-
erable amount of research has investigated the causes of SIDS, but little research has been 
conducted to identify a potential therapy that may decrease an individuals’ vulnerability 
to SIDS. Malnutrition during pregnancy and early postnatal life has well-documented del-
eterious effects on brain differentiation and growth (Gressens et al., 1997; Guesry, 1998). 
Much less understood are the effects of malnutrition on brainstem homeostasis. 
A complete understanding of SIDS etiology remains elusive. One hypothesis is that 
abnormal brainstem serotonin (5-HT) mechanisms in regions responsible for homeostatic 
control of pH may enhance SIDS vulnerability (Duncan et al., 2010; Hodges and Richerson, 
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2010; Kinney et al., 2009; Paterson et al., 2006). Such vulnerability may result from dys-
function in reflex responses to potentially life threatening conditions, such as exposure to 
harmful CO2 levels. This hypothesis is supported by animal studies demonstrating the 
physiological consequences of various levels of experimentally-induced 5-HT dysfunction 
(Hodges and Richerson, 2008; Hodges et al., 2008, 2011). Furthermore, post-mortem ex-
amination of infants who succumbed to SIDS show evidence of altered 5-HT mechanisms 
(Duncan et al., 2010; Kinney et al., 2009). Since that observation, research has indicated 
that the consequences of 5-HT dysfunction are widely varied, and implicates some such 
dysfunction in SIDS (Cummings et al., 2009; Kinney et al., 2009). One potential 5-HT-me-
diated process that is thought to be impaired in SIDS is CO2 ventilatory chemoresponsive-
ness (Richerson, 2004).  
Central CO2 chemoresponsiveness is a complex system function that involves a 
limited but varied group of neuron types, brainstem sites and multiple neurotransmitter 
mechanisms (Feldman et al., 2003; Mitchell et al, 1990; Nattie, 2009; Nattie and Li, 2009; 
Putnam et al., 2004). This organization affords the potential for considerable plasticity in 
central CO2 chemoresponsiveness to maintain pH homeostatic regulatory function de-
spite dysfunctional mechanisms, injury or disease (Feldman et al., 2003). Thus, if one re-
flex mechanism is dysfunctional another alternative mechanism may be present or en-
hanced to allow an appropriate response. In addition, ventilatory responsiveness to CO2 
is a system function for which more than one single mechanism is responsible. Because 
of this, different mechanisms likely play larger or smaller roles during specific situations. 
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In addition, some mechanisms may be important enough that their dysfunction causes 
severe consequences. There is strong evidence for an important role of 5-HT in CO2 
chemoresponsiveness. However, certain types of 5-HT dysfunction, and even complete 
absence of 5-HT, does not abolish chemoresponsiveness. Recently, a study using a mater-
nal dietary tryptophan (Trp) restriction model showed reduced medullary 5-HT and a re-
sulting impairment of the hypercapnic ventilatory response (Penatti et al., 2011). In addi-
tion, several genetic methods have been used to investigate 5-HT and its role in CO2 
chemoresponsiveness. CO2 responsiveness is impaired in male, but not female, Pet-1 
knockout mice, which lack ≈ 70 % of 5-HT neurons (Hodges et al., 2011). Furthermore, 
neonatal mice with genetic deletion of Lmx1b in neurons expressing Pet-1 (Lmx1bf/f/p), 
which have a selective and severe deficit (> 99 %) of 5-HT neurons, display a ≈ 50 % re-
tention in the hypercapnic ventilatory response (Hodges and Richerson, 2008; Hodges et 
al., 2008). These examples of different types of induced 5-HT brainstem reductions 
demonstrate the remarkable plasticity of the ventilatory CO2 chemoresponsive reflex to 
compensate for a decrease in 5-HT. The presence of any residual hypercapnic ventilatory 
responsiveness in Lmx1bf/f/p mice is somewhat surprising considering the importance of 
5-HT. However, the organism likely accommodated for the complete loss of 5-HT through 
the strengthening of alternative reflex pathways. This accommodation may also be re-
sponsible for the residual hypercapnic responsiveness observed in the other examples of 
5-HT reduction previously mentioned. These results suggest that the system function in-
cludes multiple mechanisms and is plastic.  
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In the current study, we propose that the abnormal CO2 chemoresponsive reflex 
associated with dietary Trp restriction (presumably resulting in 5-HT reduction) may be 
reduced or reversed by stimulating reflex plasticity. Prior work has shown that CO2 not 
only activates excitatory 5-HT neurons in the medullary raphé, which are known to par-
ticipate in respiratory control, but also deactivates inhibitory γ-aminobutyric acid (GABA) 
raphé neurons (Corcoran et al., 2009; Iceman et al., 2010; Wang et al., 1998; Zhang et al., 
2003). In one model, CO2-mediated deactivation of the inhibitory GABA raphé pathway 
may lead to disinhibition of downstream targets, potentially stimulating breathing. Thus, 
in this model, the excitatory 5-HT and inhibitory GABA pathways are thought to behave 
in a push-pull manner to modulate ventilatory activity (Corcoran et al., 2008; Richerson, 
1995). The present study used a previously described intermittent hypercapnia-pretreat-
ment protocol (IHc; elevated arterial CO2 concentration; Mosher et al., in review) in an 
attempt to reduce or overcome the abnormal ventilatory CO2 reflexes induced by mater-
nal dietary Trp restriction. Because our dietary restriction protocol was identical to that 
of Penatti et al. (2011), the abnormal ventilatory CO2 reflexes resulting from Trp dietary 
restriction are thought to be due to a partial 5-HT reduction, as theirs was. This dietary 
restriction protocol was selected for its biological relevance and because of the link be-
tween poverty and increased SIDS risk (Bavis, 2011; Malloy and Eschbach, 2007). We 
tested the hypothesis that IHc-pretreatment during postnatal development enhances hy-
percapnic responsiveness to overcome ventilatory abnormalities induced through mater-
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nal dietary Trp restriction. If induced reflex plasticity is able to overcome or reverse ven-
tilatory CO2 chemoresponsiveness dysfunctions that are thought to underlie SIDS, the fac-
tors that induce plasticity may be therapeutic in decreasing vulnerability to SIDS. 
 
3.3 Methods 
Experimental groups: All experiments were done in accordance with the guidelines of the 
“Guide for the Care and Use of Laboratory Animals” of the National Institutes of Health 
and were approved by the University of Alaska Fairbanks (UAF) Institutional Animal Care 
and Use Committees. As previously described by Penatti et al. (2011), Sprague-Dawley 
naive adult female rats (Simonson Laboratories) were fed normal rat chow in which tryp-
tophan (Trp) was present in normal or reduced levels (Harlan Teklad). The control diet 
was composed (g/kg) of the following ingredients: 3.5 L-alanine, 12.1 L-arginine HCl, 6.0 
L-asparagine, 3.5 L aspartic acid, 3.5 L-cystine, 40.0 L-glutamic acid, 23.3 glycine, 4.5 L-
histidine HCl, monohydrate, 8.2 L-isoleucine, 11.1 L-leucine, 18.0 L-lysine HCl, 8.2 L-me-
thionine, 7.5 L-phenylalanine, 3.5 L-proline, 3.5 L-serine, 8.2 L-threonine, 1.8 L-trypto-
phan, 5.0 L-tyrosine, 8.2 L-valine, 351.68 sucrose, 150.0 corn starch, 150.0 maltodextrin, 
80.0 soybean oil, 30.0 cellulose, 35.0 mineral mix, 8.2 calcium phosphate, monobasic, 
monohydrate, 13.0 vitamin mix, 2.5 choline bitartrate, and 0.02 tertiary butylhydroqui-
none, an antioxidant. The control and Trp-deficient diets were equivalent except for the 
deficient diet contained a reduced 1 g/kg level of Trp, about 55 % of the estimated nutri-
tional requirement.  
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Five naïve female rats received normal rat chow and water ad libitum, and they 
were bred with 5 different males. Six naïve female rats received Trp-deficient rat chow 
and water ad libitum, and they were bred with 6 different males. All animals received 
their respective diet ad libitum for 2 weeks prior to mating, during gestation and postna-
tally. Resulting pups also received their respective diet (Trp-deficient or control) and wa-
ter ad libitum and were housed and maintained in the UAF Animal Care Facility on a 12 h 
light/dark cycle, at a room temperature of 21 °C. A total of 74 animals from both sexes 
were studied.  
Gas pretreatments: Rat pups were exposed to intermittent hypercapnia (IHc; 8 
consecutive cycles of 5 min 5 % CO2: balance air, followed by 10 min air) or constant 
normocapnia as a control (Nc; Type 1-Grade D air only, as a treatment sham) each day for 
5 consecutive days beginning at post-natal day 12 (P12). Entire litters were randomly as-
signed to either IHc- or Nc-pretreatment. Because related litter-mates, rather than ran-
domly assigned individuals, were used as experimental subjects, multiple litters (2 to 5) 
received each combination of gas and pharmacological treatments. During gas treat-
ments, dams were separated from pups and the home cage was transported to a proce-
dure room adjacent to the animal holding area. Cages were fitted with an airtight lid with 
a gas inflow and outflow. In this manner, litters (ranging from 3 to 15 pups) were exposed 
to room temperature inlet gas, supplied at 10 l/min through a countercurrent heat ex-
changer. The gas outlet was connected to 1 m of 5.5 mm internal diameter tubing to pre-
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vent room air infiltration without creating substantial positive pressure within the cham-
ber. For intermittent gas exposure, a programmable digital timer and solenoid valve au-
tomatically switched inlet gases between the two sources. This apparatus produced a 10-
min period of normocapnia followed by 8 repeated cycles of 5-min hypercapnia (or 
normocapnia in controls) and 10-min normocapnia. Valve cycling was monitored using a 
computerized data acquisition system (LabChart 7, ADInstruments). Pilot studies indi-
cated that CO2 levels in the enclosure equilibrated with inlet gas concentrations within 90 
s. Chamber gas was not monitored during these treatments. After this exposure protocol, 
cages were removed from the enclosure, dams were returned to pups in the home cage 
and cages were returned to the adjacent housing facility. In no cases did pup abandon-
ment occur following these brief maternal separations, and patterns and durations of ma-
ternal separation were equal between IHc and Nc treatment groups. Exposure protocols 
were repeated on 5 consecutive days, at approximately the same time each day. 
In situ assessment of CO2 chemoresponsiveness: At least 7 days following IHc- or 
Nc-pretreatment, hypercapnic ventilatory responsiveness was assessed using the in situ 
arterially perfused brainstem preparation as previously described (Corcoran et al., 2013; 
Toppin et al., 2007, after Paton, 1996). Briefly, animals were anesthetized with isoflurane 
(5 %, vaporized in 100 % O2) and pretreated with heparin sodium (500 units, I.P.). Animals 
were bisected subdiaphragmatically and submerged in an ice-chilled artificial cerebral spi-
nal fluid (aCSF) containing (mM in H2O): MgSO4·7H2O, 1; NaH2PO4H2O, 1.25; KCl, 4; Na-
HCO3, 24; NaCl, 115; D-glucose, 10; CaCl2·2H2O, 2). The forebrain rostral to the colliculi 
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was removed by aspiration, and fur, skin and viscera were removed. The diaphragm was 
separated from the body wall with care taken to ensure integrity of the phrenic nerve. 
The preparation was moved to the recording station where the descending aorta was 
cannulated using a double-lumen catheter (Ø 1.25 mm, Braintree Scientific) and perfused 
retrogradely from a reservoir containing 350 ml aCSF (with 13 g/l ficoll 70, Sigma, added 
as an osmotic agent). The perfusate was first equilibrated with 95 % O2-5 % CO2 
(normocapnia, pH 7.4, PCO2 of 33 mmHg). Equilibration mixtures were produced from O2 
and CO2 using a precision gas mixer (GSM3, CWE) and verified with a CO2 analyzer (CD-
3A, Applied Electrochemistry). Normocapnic (baseline) conditions approximated 
normocapnic plasma in vivo.  Lacking hemoglobin, solution hyperoxia (Po2 ≈ 600 mmHg) 
was necessary to maintain O2 content sufficient to meet tissue metabolic demands. This 
unavoidable hyperoxia was constant under all conditions. Perfusate was warmed to 32 
°C, and circulated through a bubble trap and particle filters (25 μm, 45 μm; Millipore) prior 
to entering the aorta. Perfusate passing through the animal was collected and recycled to 
the reservoir. The neuromuscular blocker gallamine triethiodide (20 mg/l), and the vaso-
constriction hormone vasopressin (5 μM) were added to the perfusate. The aortic perfu-
sion pressure was adjusted to 70-80 mmHg using an adjustable perfusate bypass valve 
and a bolus of sodium cyanide (50 μl 0.1 % solution) was injected into the perfusate line 
to transiently stimulate peripheral chemoreceptors (Dutschmann et al., 2000). After par-
tial pulmonectomy, the phrenic nerve was exposed and aspirated into a glass capillary 
suction electrode pulled to a diameter that ensured adequate seal on the nerve.  
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The signal was amplified (×10,000; DAM50, WPI) and filtered (band-pass 300 Hz – 
1 kHz). Using a computerized data acquisition system (Powerlab, ADInstruments), data 
were digitized at 1 k Samples/s and digitally integrated through full wave rectification and 
50 ms moving average on a duplicate channel. Phrenic burst frequency (f, bursts/min) was 
determined by counting the number of phrenic bursts occurring during 60 s of normocap-
nia immediately preceding the gas challenge, the final 60 s of hypercapnia, and 60 s during 
normocapnic recovery 5 min after a return to baseline. Phrenic burst amplitude was de-
rived from the mean integrated peak height of all bursts within these 60 s periods, ex-
pressed in arbitrary units within each preparation and as a proportional change within a 
preparation in response to the gas challenge. Neural minute ventilation (NVE) was calcu-
lated as the product of burst frequency and amplitude, again expressed in arbitrary units 
and as a proportional change with treatment (Eldridge, 1971). 
Gas Challenges: Preparations were maintained on normocapnic perfusate for at 
least 1 h. For the gas challenge, gas equilibrating the perfusate was switched in sequence 
to 5-min periods of hypocapnia (96.5 % O2-3.5 % CO2; pH 7.5; PCO2 ≈ 23 mmHg) followed 
by 5-min periods of hypercapnia (91 % O2-9 % CO2; pH 7.2; PCO2 ≈ 60 mmHg) and subse-
quently returned to baseline normocapnia.  The hypercapnic challenge conditions approx-
imated those occurring during a 4 % increase in inspired CO2. 
Data and statistical analyses: Ventilatory parameters were quantified from the 
integrated neurograms. Frequency (f; the number of bursts per unit time), amplitude (the 
mean integrated peak amplitude of bursts), and a neural correlate of minute ventilation 
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(NVE; frequency•amplitude) were calculated from periods of normocapnia or hypercap-
nia. Hypercapnic responsiveness was determined from ventilatory parameters recorded 
during baseline normocapnia and hypercapnia. This was quantified by deriving a relative 
hypercapnic response, calculated by expressing the difference in parameter values be-
tween normocapnia and hypercapnia, normalized as a percentage relative to values oc-
curring during normocapnia prior to gas challenge (responsiveness = [value during hyper-
capnia – value during normocapnia] / value during normocapnia).  
Data Parsing: We and others have demonstrated that the in situ rat brainstem 
preparation exhibits clear responsiveness to hypercapnia and provides an appropriate 
model for the study of mechanisms contributing to chemosensitivity (Corcoran et al., 
2013; Day and Wilson, 2007; Iceman et al., 2013; Toppin et al., 2007). These prior studies 
have illustrated that the response is most clearly manifested by changes in burst fre-
quency and the index of minute ventilation, NVE. Our pilot investigations suggested the 
possibility that preparations exhibiting a relatively high initial burst frequency have a 
lower apparent responsiveness to hypercapnia, which suggests a frequency limitation. 
The present study was designed to determine chemosensory mechanisms, necessitating 
a focus on responsive preparations free of potential confounding factors. 
To remove the potential confounding influence of dampened chemoresponsive-
ness in preparations with elevated baseline burst frequencies, we subjected the data to 
the following parsing protocol. In preparations exposed to neither dietary restriction nor 
IHc, we plotted the relationship between hypercapnic responsiveness and initial burst 
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frequency and determined a linear regression (P < 0.001; R2 = 0.74) described by the equa-
tion hypercapnic responsiveness (HcR) = 192 – 3.45 (initial frequency). The highest sensi-
tivity observed in any of these preparations was 184.6. A half-maximum value was used 
to determine a threshold initial burst frequency identifying preparations for which high 
initial frequency could confound subsequent responsiveness. Preparations having an ini-
tial burst frequency above this threshold were not included in the dataset. When so 
parsed, 16 of 74 preparations (21 %) were removed from analyses; a total of 58 prepara-
tions contributed to the data set.    
One-way repeated-measures analysis of variance (RM-ANOVA) was used to com-
pare frequency, amplitude or NVE parameters before and during hypercapnia for each 
preparation, which quantified hypercapnic responsiveness for these three ventilatory pa-
rameters. One-way ANOVA was used to compare the effect of dietary restriction and IHc 
treatment on the hypercapnia-induced change in each parameter. For each parameter (f, 
amplitude and NVE) in each experiment we calculated the % change from normocapnia = 
[(parameter during hypercapnia – parameter during normocapnia) / parameter during 
normocapnia)] • 100 %. Values reported in the text are mean ± standard error. To com-
pare the mean hypercapnic responsiveness for each parameter between groups, a Tukey 
post-hoc analysis was used following a significant ANOVA. 
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3.4 Results 
Burst discharge recordings: All our recorded phrenic neurograms displayed a “eupneic” 
pattern (Fig. 3.1) characteristic of this preparation (Eldridge, 1971; St.-John and Paton, 
2000), and displayed this pattern throughout normocapnia, hypercapnia and normocap-
nic recovery.  
Preparations derived from pups maintained on the control diet that were Nc-pre-
treated had an average normocapnic burst frequency of 20.7 ± 1.26 bursts/min (data from 
Chapter 2). Hypercapnic responsiveness in these preparations was also typical of past re-
ports (Corcoran et al., 2008; Mosher et al., in review; St.-John et al., 2007), reflected by 
an increase in burst frequency and amplitude, and thus NVE as well, during hypercapnia 
compared to normocapnia (Fig. 3.1).   
Hypercapnic responsiveness with control and tryptophan-deficient diets: Hyper-
capnic responsiveness is characterized by proportional change from normocapnic values, 
expressed as a % change (Figs. 3.2, 3.3, 3.4). In preparations derived from pups exposed 
to the control diet and Nc-pretreatment, normalized hypercapnic burst frequency values 
were elevated (22 ± 5.0 %) from baseline values indicating hypercapnic responsiveness (P 
< 0.001; Fig. 3.2, data reported in Chapter 2). Similarly, CO2 responsiveness was also 
shown by a 27 ± 14 % increase in NVE with hypercapnia in these preparations (P < 0.05; 
Fig. 3.3, data reported in Chapter 2). In preparations from pups maintained on the Trp-
deficient diet that were Nc-pretreated, burst frequency also increased 27.1 ± 9.08 % with 
hypercapnia (P < 0.001; Fig. 3.2), although NVE was unchanged (Fig. 3.3). 
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Effect of IHc on hypercapnic responsiveness with control and tryptophan-deficient 
diets: Preparations from pups maintained on the control diet that were IHc-pretreated 
increased burst frequency and NVE with hypercapnia (38 ± 11 %, 130 ± 58 % respectively; 
P < 0.001; Figs. 3.2, 3.3). For preparations from pups maintained on the control diet that 
were IHc-pretreated, hypercapnic responsiveness in burst frequency was equal while in-
creases in NVE were greater than those observed in the Nc-pretreated group (P < 0.05; 
Fig. 3.3). Hypercapnia increased burst frequency in preparations from pups maintained 
on the Trp-deficient diet that were IHc-pretreated (16 ± 3.1 %; P < 0.001; Fig. 3.2; equal 
to control diet Nc-pretreated controls), and NVE also increased by proportions equal to 
those of control diet Nc-pretreated controls (29 ± 7.0 %; P < 0.01; Fig. 3.3; equal to control 
diet Nc-pretreated controls). 
 
3.5 Discussion 
Our study assessed if pretreating with IHc during postnatal development could induce 
ventilatory plasticity to overcome the reduced CO2 chemoresponse associated with die-
tary Trp restriction. Penatti et al. (2011) demonstrated that rats maintained on the same 
dietary Trp restriction protocol used in the current study had a 41–56 % reduction in 
brainstem medullary 5-HT. This model has been suggested to be particularly pertinent to 
studies of infant vulnerability to SIDS as dietary-restricted pups exhibit a partial tissue 5-
HT reduction and represent a close approximation to the 5-HT defect in SIDS infants (Pe-
natti et al., 2011). Although we are not certain, we assume that a similar reduction of 
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medullary 5-HT was induced by the Trp-deficient diet in the current study. In addition, 
similar CO2 ventilatory chemoresponsive deficits were observed.  
Our results confirm that the rat in situ perfused brainstem preparation does ex-
hibit CO2 responsiveness (Corcoran et al., 2013; Day and Wilson, 2007). Preparations de-
rived from animals that were maintained on the Trp-deficient diet and Nc-pretreated did 
not exhibit NVE CO2 chemoresponsiveness. Although this group did exhibit ventilatory 
frequency CO2 chemoresponsiveness, this was not particularly surprising as the dietary 
Trp restriction previously resulted in only a modest dysfunction in CO2 chemoresponsive-
ness (Penatti et al., 2011).  
The hypercapnic ventilatory response is a complex system function that involves 
multiple neuron types, brainstem sites and neurotransmitter mechanisms (Feldman et al., 
2003; Nattie, 2009; Nattie and Li, 2009; Putnam et al., 2004). Diverse mechanisms con-
tribute to this system function, allowing for plasticity to provide homeostatic regulation 
despite dysfunction in any one mechanism (Feldman et al., 2003).  
We aimed to evaluate if plasticity induced through IHc-pretreatment could over-
come the impaired CO2 chemoresponse associated with dietary Trp restriction. We pro-
pose that CO2 chemoresponsive plasticity can be induced by IHc-pretreatment to precon-
dition the system and enhance alternate mechanisms to compensate for the dysfunc-
tional processes induced by Trp restriction. 
We used the same IHc-pretreatment regimen that we previously described in the 
first report of an IHc-induced enhancement of CO2 chemoresponsiveness (Mosher et al., 
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in review). In these experiments, IHc-pretreatment was initiated on P12 and continued 
daily through P16. Protocols were designed to administer cycles of mild hypercapnia to 
pups, without altering maternal conditions and while limiting maternal separation. This 
developmental period was chosen to follow the apparent critical period proximal to P12 
where rat CO2 chemosensitivity is altered (Putnam et al., 2005; Wong-Riley and Liu, 2005; 
2008), and the developmental period beyond which CO2 chemosensitive 5-HT neurons 
have been identified in vitro (Wang and Richerson, 1999). Prior attempts to influence hy-
percapnic responsiveness showed no influence when a comparable IHc protocol was con-
ducted between P7 and P14 (Steggerda et al., 2009). It is likely that the developmental 
timing and/or nature of the IHc stimulus influences resultant plasticity.  
We show that the plasticity induced by IHc-pretreatment is capable of overcoming 
the CO2 chemoresponse dysfunction produced by dietary Trp restriction. Animals main-
tained on the Trp-deficient diet did not exhibit NVE CO2 chemoresponsiveness in prepa-
rations that were Nc-pretreated. Both frequency and NVE CO2 chemoresponsiveness per-
sisted, however, in preparations maintained on the Trp-deficient diet that were IHc-pre-
treated. The frequency and NVE responses were no different than those observed in con-
trol diet Nc-pretreated preparations. In addition, both frequency and NVE CO2 
chemoresponsiveness for preparations maintained on the Trp-deficient diet that were 
IHc-pretreated were no different than those observed in Trp-deficient preparations that 
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were Nc-pretreated. We attribute the retention of relatively normal CO2 chemorespon-
siveness in the Trp-deficient IHc-pretreated group to plasticity imparted by IHc-pretreat-
ment.  
The organization of respiratory chemosensitivity as a system function grants the 
potential for considerable plasticity. Not only do particular mechanisms play differential 
roles in overall system sensitivity under particular conditions, the involvement of multiple 
mechanisms permits homeostatic pH regulation despite partial dysfunction, injury or dis-
ease (Feldman et al., 2003). Thus, if one reflex mechanism is dysfunctional, alternative 
mechanisms can often accommodate an appropriate response. We have previously 
shown that IHc-pretreatment enhances a ketanserin-insensitive mechanism not normally 
critical for CO2 responsiveness. In addition we have demonstrated that plasticity induced 
by IHc-pretreatment is due to the enhancement of bicuculline- and saclofen-sensitive 
mechanisms (Mosher et al., in review). It may be that the plasticity induced by IHc-pre-
treatment observed in the current study is also due to similar mechanisms. Further inves-
tigations are necessary.  
Critique of methods: Our use of the dietary restriction model is based on the ear-
lier finding that this Trp-restriction induced a partial tissue 5-HT reduction that represents 
a physiologically relevant animal model to the partial 5-HT dysfunction associated with 
SIDS (Penatti et al., 2011). We confirm the results of this earlier study both in that the 
dietary Trp restriction induced a measurable deficit in CO2 chemoresponsiveness and that 
this deficiency is subtle. However, despite the similarity in the dysfunctional CO2 
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chemoresponse, we are not able to assume that the dysfunction that we observe is due 
to 5-HT reduction as seen by Penatti et al., (2011) as we did not measure tissue 5-HT 
levels. In our hands, dietary restriction abolished the NVE component of CO2 
chemoresponsiveness, while in Penatti’s study this dietary treatment reduced the magni-
tude of ventilatory CO2 chemoresponsiveness resolved from changes in minute ventila-
tion normalized to metabolic rate (VE/VO2). Also, as was acknowledged in Pennati’s report 
(2011), our use of the dietary restriction model incorporated an unavoidable pseudorepli-
cation. Control and Trp-deficient diets were administered to the dam 2 weeks prior to 
mating, during gestation and postnatally and maintained in all of the pups in a litter. Alt-
hough it would be a more powerful experimental design to study only one pup from mul-
tiple treated litters, we also chose to study all pups in fewer litters to avoid excess animal 
use. Additionally, although animals in our study were maintained on the same control and 
Trp-deficient diets, there may have been unforeseen variables that could have resulted in 
different levels of tissue 5-HT reduction than seen by Penatti et al. (2011). 
 
3.6 Conclusion 
In this study, we used a previously described biologically relevant model for the Sudden 
Infant Death Syndrome susceptibility on account of poor nutrition and subsequent dimin-
ished levels of brainstem 5-HT (Penatti et al., 2011). The degree to which ventilatory CO2 
chemoresponsiveness was impacted by dietary Trp restriction was then observed. This 
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dietary Trp restriction model was used to test the effectiveness of a potential therapy, 
IHc-pretreatment, which was designed to induce reflex plasticity. 
We confirm the finding that animals maintained on a Trp-deficient diet exhibit a 
partially dysfunctional hypercapnic response, suggesting contributions mediated by die-
tary Trp are important for CO2 responsiveness under these conditions. We show that IHc-
pretreatment induces plasticity such that CO2 chemoresponsiveness is maintained de-
spite dietary Trp restriction. 
Serotonergic dysfunction likely contributes to a number of pathologies, including 
SIDS, by compromising homeostatic reflexes such as hypercapnic chemoresponsiveness. 
It may be that plasticity induced by IHc-pretreatment could enhance pH homeostatic re-
flex efficacy and potentially reduce vulnerabilities to conditions such as SIDS and other 
respiratory pathologies thought to be the result of CO2 chemoresponse dysfunction. A 
number of critical factors remain unknown. These include exact mechanisms involved in 
plasticity induced by IHc-pretreatment, the longevity of this plasticity, and potential de-
velopmental sensitivities to plasticity induced by IHc-pretreatment. The clear potential to 
induce CO2 chemoresponse plasticity, however, provides possible targets for therapeutic 
intervention to reverse CO2 chemoresponsive dysfunction. 
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3.8 Figures 
See below where figures are displayed on full pages. 
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Figure 3.1 Eupneic phrenic ventilatory burst in situ. Typical phrenic neurogram re-
cording with spikes indicating respiratory bursts. During the in situ preparation when the 
organism was exposed to perfusate containing 9 % CO2 (hypercapnia; bottom panel) there 
was an increase in both frequency and NVE (frequency*amplitude) of respiratory events, 
when compared to experiencing 5 % CO2 (normocapnia; top panel). Both of the above 
panels are representative tracings from the last minute of the indicated CO2 treatment. 
Tracings taken from a preparation derived from a pup that received control diet and Nc-
pretreatment without pharmacological manipulation. Tracings reported here are the 
same used in Chapter 2. 
 
 
 
5 % CO2 
9 % CO2 
5 sec 
5 sec 
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Figure 3.2 Influence of IHc on frequency response to hypercapnia for preparations 
derived from animals maintained on control and tryptophan-deficient diets. Hypercap-
nia increased ventilatory f, normalized to normocapnia, in preparations derived from 
pups that received control diet and were Nc-pretreated (no fill bar, n = 20, same data as 
reported in Chapter 2), those that received experimental diet and were Nc-pretreated 
(solid fill bar, n = 9), those that received control diet and IHc-pretreatment (horizontal 
stripe bar, n = 16) and those that received experimental diet and IHc-pretreatment (ver-
tical stripe bar, n = 13). Each bar represents mean ± SE. Significant increase from 
normocapnia to hypercapnia (one-way RM-ANOVA): *P < 0.05; **P < 0.01; ***P < 0.001. 
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Between groups comparison of difference in hypercapnic responsiveness determined us-
ing one-way ANOVA: †P < 0.05. 
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Figure 3.3 Influence of IHc on NVE response to hypercapnia for preparations de-
rived from animals maintained on control and tryptophan-deficient diets. Hypercapnia 
increased ventilatory NVE, normalized to normocapnia, in preparations derived from 
pups that received control diet and were Nc-pretreated (no fill bar, n = 20, same data as 
reported in Chapter 2), those that received control diet and were IHc-pretreated (hori-
zontal stripe bar, n = 16) and those that received experimental diet and IHc-pretreatment 
(vertical stripe bar, n = 13). Each bar represents mean ± SE. Significant increase from 
normocapnia to hypercapnia (one-way RM-ANOVA): *P < 0.05; **P < 0.01; ***P < 0.001. 
Between groups comparison of difference in hypercapnic responsiveness determined us-
ing one-way ANOVA: †P < 0.05. 
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Figure 3.4 Influence of IHc on amplitude response to hypercapnia for preparations 
derived from animals maintained on control and tryptophan-deficient diets. Hypercap-
nia failed to increase ventilatory amplitude, normalized to normocapnia. Each bar repre-
sents mean ± SE. Between groups comparison of difference in hypercapnic responsive-
ness determined using one-way ANOVA failed to reveal any difference between groups. 
Bar describing preparations without drugs that were Nc-pretreated (no fill bar) are data 
previously reported in Chapter 2. 
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Chapter 4 
Intermittent hypercapnia induces long-lasting plasticity to enhance ventilatory CO2 re-
sponsiveness to overcome ketanserin-sensitive dysfunction1 
4.1 Abstract 
Abnormal homeostatic responses to increased levels of CO2 are associated with numer-
ous dangerous or life-threatening disorders. We test the hypothesis that exposure to mild 
intermittent hypercapnia (IHc) during postnatal development will induce long-lasting res-
piratory plasticity, due to the strengthening of non ketanserin-sensitive mechanisms. Rat 
pups were exposed to a previously described IHc protocol (Mosher et al., in review) each 
day for 5 days beginning at postnatal day 12 (P12), and were subsequently assessed for 
CO2/pH chemoresponsiveness using an unanesthetized juvenile rat in situ perfused dece-
rebrate brainstem preparation. Neuroventilatory response to CO2 was tested during three 
age groups; P21-35, P36-50 and P51-65. Such CO2 chemoresponsiveness was greatly en-
hanced by IHc-pretreatment through the strengthening of non-ketanserin-sensitive con-
tributions resulting in preserved CO2 chemoresponsiveness when ketanserin-sensitive 
mechanisms were compromised. Results indicate that IHc-pretreatment induces long-
lasting CO2 chemoresponsive plasticity and strengthens non-ketanserin-sensitive contri-
butions persisting far into adult life (at least through P65). 
 
 
1 Mosher BP, Taylor BE, Harris MB. Intermittent hypercapnia induces long-lasting plasticity to enhance 
ventilatory CO2 responsiveness to overcome ketanserin-sensitive dysfunction. In preparation for publica-
tion in Resp. Physiol. Neurobiol. 
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4.2 Introduction 
Enabling animals to adapt to changes in environmental conditions and behavior, plasticity 
is a fundamental characteristic of neural systems. A considerable amount of research in 
recent years has revealed that the neural mechanisms controlling respiration are capable 
of exhibiting remarkable plasticity. Central CO2 chemoreception is a complex system func-
tion that involves a limited but varied group of neuron types, brainstem sites and multiple 
neurotransmitter mechanisms (Feldman et al., 2003; Mitchell et al., 1990; Nattie, 2009; 
Nattie and Li, 2009; Putnam et al., 2004). Different mechanisms contribute to CO2 respon-
siveness under different conditions. Organization of CO2 chemosensitivity as a system 
function affords the potential for considerable plasticity. Not only could a specific mech-
anism play a differential role in overall system sensitivity under specific conditions, the 
involvement of multiple mechanisms may allow homeostatic regulation despite partial 
dysfunction, injury or disease (Feldman et al., 2003). Thus, if one reflex mechanism is dys-
functional, alternative mechanisms likely facilitate an appropriate response.   
Many protocols using different respiratory chemoreceptor stimuli (hypoxia and 
hypercapnia), durations, intensities and patterns have been shown to evoke distinct 
forms of plasticity in respiratory control. These resulting forms of plasticity often differ in 
their effect (facilitation or depression) on different ventilatory parameters (frequency and 
tidal volume), their time course (seconds to years) and response to different challenges 
(hypoxia and hypercapnia). Thus, the specific stimulus paradigm appears to be of great 
importance.  
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Hypoxia-induced respiratory plasticity is widely considered to be the most thor-
oughly studied and best understood form of respiratory plasticity. Depending on the spe-
cific exposure protocol, various forms of plasticity may be induced. After a single hypoxic 
episode, a short-term depression of phrenic motor output (post-hypoxia frequency de-
cline) is observed in anesthetized rats (Coles and Dick, 1996). However, when intermittent 
hypoxia is administered, various unique forms of plasticity are elicited. Elevated respira-
tory activity during normoxic exposures between successive hypoxic episodes is often ob-
served, reflecting the development of long-term facilitation (LTF; Powell et al., 1998). Per-
sistent elevation of respiratory motor output, lasting minutes to hours, is the subsequent 
result of 3-10 hypoxic episodes, with each episode varying in duration depending on spe-
cific protocol (Mitchell et al., 2001). Furthermore, LTF is elicited by intermittent but not 
continuous hypoxia (Baker and Mitchell, 2000). If intermittent hypoxia persists, different 
mechanisms of plasticity are evoked. For example, chronic intermittent hypoxia augments 
the short-term hypoxic ventilatory response, eliminates post-hypoxia frequency decline, 
and enhances LTF in rats (Ling et al., 2001). Just as different hypoxic stimulus protocols 
vary in their capacity to evoke respiratory plasticity, hypercapnic stimulus protocols also 
induce respiratory plasticity to varying degrees. 
Although receiving less attention, and relatively poorly understood, hypercapnia 
is also capable of eliciting various forms of respiratory plasticity. In contrast to intermit-
tent hypoxia, intermittent hypercapnia (≈ 10 % inspired CO2) has been reported to elicit 
long-term depression (LTD), a long-lasting decrease in the frequency and amplitude of 
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respiratory motor output (Bach and Mitchell, 1998). However, LTD is not evoked by less 
severe levels of hypercapnia (≈ 5 % CO2). In contrast to the previous report by Bach and 
Mitchell (1998), Baker et al. (2001) found that intermittent hypercapnia did not elicit sig-
nificant LTD of phrenic amplitude, but significant LTD of burst frequency was resolvable. 
In contrast to episodic hypercapnia, Baker et al. (2001) found that continuous hypercap-
nia did elicit prolonged LTD. Steggerda et al. (2009) examined the effects of daily exposure 
to intermittent hypercapnia on the ventilatory response to subsequent hypercapnic and 
hypoxic exposure in neonatal rat pups. In response to a subsequent hypercapnia chal-
lenge, there was no significant difference in the ventilatory response between control and 
intermittent hypercapnia-exposed groups. In contrast, intermittent hypercapnia-exposed 
rat pups exhibited an enhanced ventilatory response to a hypoxic challenge with an in-
crease in minute diaphragmatic electromyogram (EMG; Steggerda et al., 2009). In addi-
tion, rat pups that were exposed to perinatal hypercapnia exhibited only a transient re-
duction in the hypercapnic ventilatory response (Bavis et al., 2006). Collectively, these 
data suggest that the duration, intensity and pattern of chemosensory stimuli protocol 
used are of great importance when investigating the respiratory plasticity evoked by both 
hypoxia and hypercapnia exposure protocols.  
Studying respiratory plasticity may provide insights into mechanisms that control 
normal development of the respiratory control system and that enable flexibility through-
out life when confronted with changing environmental conditions. In addition, an under-
standing of respiratory plasticity may yield insights into various respiratory pathologies, 
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thereby providing the rationale for therapeutic intervention in cases of respiratory dys-
function, such as the Sudden Infant Death Syndrome (SIDS).  
We propose that the CO2 chemoresponsive plasticity invoked by an intermittent 
hypercapnia (IHc) protocol, which has previously been shown to precondition the system 
and enhance multiple chemosensory mechanisms (Mosher et al., in review) is capable of 
inducing long-lasting respiratory plasticity that persists far into life. We test the hypothe-
sis that IHc-pretreatment during postnatal development will induce long-lasting respira-
tory plasticity. 
Abnormal homeostatic responses to increased levels of CO2 are associated with 
numerous dangerous or life-threatening disorders, including SIDS. If induced reflex plas-
ticity is sufficient to overcome or reverse ventilatory CO2 chemoresponsiveness dysfunc-
tions, then interventions that induce plasticity could be therapeutic in augmenting CO2 
chemoresponsiveness and decreasing vulnerability. 
 
4.3 Methods 
Experimental groups: All experiments were done in accordance with the guidelines of the 
“Guide for the Care and Use of Laboratory Animals” of the National Institutes of Health 
and were approved by the University of Alaska Fairbanks (UAF) Institutional Animal Care 
and Use Committees. Sixteen naïve rat dams received normal rat chow and water ad libi-
tum, and they were bred with 16 males. Sprague-Dawley rats were used in all experiments 
(Simonson Laboratories). Resulting pups also received food and water ad libitum and 
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were housed and maintained in the UAF Animal Care Facility on a 12 h light/dark cycle. A 
total of 49 animals from both sexes were used in these studies.  
Gas pretreatments: Rat pups were exposed to intermittent hypercapnia (IHc; 8 
consecutive cycles of 5 min 5 % CO2: balance air, followed by 10 min air) or constant 
normocapnia as a control (Nc; Type 1-Grade D air only, as a treatment sham) each day for 
5 consecutive days beginning at post-natal day 12 (P12). Entire litters were randomly as-
signed to either IHc- or Nc-pretreatment. Because related litter-mates, rather than ran-
domly assigned individuals, were used as experimental subjects, multiple litters (2 to 3) 
received each combination of gas and pharmacological treatments. During gas treat-
ments, dams were separated from pups and the home cage was transported to a proce-
dure room adjacent to the animal holding area. Cages were fitted with an airtight lid with 
a gas inflow and outflow. In this manner, litters (ranging from 3 to 8 pups) were exposed 
to room temperature inlet gas, supplied at 10 l/min through a countercurrent heat ex-
changer. The gas outlet was connected to 1 m of 5.5 mm internal diameter tubing to pre-
vent room air infiltration without creating substantial positive pressure within the cham-
ber. For intermittent gas exposure, a programmable digital timer and solenoid valve au-
tomatically switched inlet gases between the two sources. This apparatus produced a 10-
min period of normocapnia followed by 8 repeated cycles of 5-min hypercapnia (or 
normocapnia in controls) and 10-min normocapnia. Valve cycling was monitored using a 
computerized data acquisition system (LabChart 7, ADInstruments). Pilot studies indi-
cated that CO2 levels in the enclosure equilibrated with inlet gas concentrations within 90 
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s. Chamber gas was not monitored during these treatments. After this exposure protocol, 
cages were removed from the enclosure, dams were returned to pups in the home cage 
and cages were returned to the adjacent housing facility. In no cases did pup abandon-
ment occur following these brief maternal separations, and patterns and durations of ma-
ternal separation were equal between IHc- and Nc-pretreatment groups. Exposure pro-
tocols were repeated on 5 consecutive days, at approximately the same time each day. 
In situ assessment of CO2 chemoresponsiveness: At least 7 days following IHc- or 
Nc-pretreatments, hypercapnic ventilatory responsiveness was assessed using the in situ 
arterially perfused brainstem preparation as previously described (Corcoran et al., 2013; 
Toppin et al., 2007, after Paton, 1996). Briefly, animals were anesthetized with isoflurane 
(5 %, vaporized in 100 % O2) and pretreated with heparin sodium (500 units, I.P.). Animals 
were bisected subdiaphragmatically and submerged in an ice-chilled artificial cerebral spi-
nal fluid (aCSF) containing (mM in H2O): MgSO4·7H2O, 1; NaH2PO4H2O, 1.25; KCl, 4; Na-
HCO3, 24; NaCl, 115; D-glucose, 10; CaCl2·2H2O, 2). The forebrain rostral to the colliculi 
was removed by aspiration, and fur, skin and viscera were removed. The diaphragm was 
separated from the body wall with care taken to ensure integrity of the phrenic nerve. 
The preparation was moved to the recording station where the descending aorta was 
cannulated using a double-lumen catheter (Ø 1.25 mm, Braintree Scientific) and perfused 
retrogradely from a reservoir containing 350 ml aCSF (with 13 g/l ficoll 70, Sigma, added 
as an osmotic agent). The perfusate was first equilibrated with 95 % O2-5 % CO2 
(normocapnia, pH 7.4, PCO2 of 33 mmHg). Equilibration mixtures were produced from O2 
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and CO2 using a precision gas mixer (GSM3, CWE) and verified with a CO2 analyzer (CD-
3A, Applied Electrochemistry). Normocapnic (baseline) conditions approximated 
normocapnic plasma in vivo.  Lacking hemoglobin, solution hyperoxia (Po2 ≈ 600 mmHg) 
was necessary to maintain O2 content sufficient to meet tissue metabolic demands. This 
unavoidable hyperoxia was constant under all conditions. Perfusate was warmed to 32 
°C, and circulated through a bubble trap and particle filters (25 μm, 45 μm; Millipore) prior 
to entering the aorta. Perfusate passing through the animal was collected and recycled to 
the reservoir. The neuromuscular blocker gallamine triethiodide (20 mg/l), and the vaso-
constricting hormone vasopressin (5 μM) were added to the perfusate. The aortic perfu-
sion pressure was adjusted to 70-80 mmHg using an adjustable perfusate bypass valve 
and a bolus of sodium cyanide (50 μl 0.1 % solution) was injected into the perfusate line 
to transiently stimulate peripheral chemoreceptors (Dutschmann et al., 2000). After par-
tial pulmonectomy, the phrenic nerve was exposed and aspirated into a glass capillary 
suction electrode pulled to a diameter that ensured adequate seal on the nerve.  
The signal was amplified (×10,000; DAM50, WPI) and filtered (band-pass 300 Hz – 
1 kHz). Using a computerized data acquisition system (Powerlab, ADInstruments), data 
were digitized at 1 k Samples/s and digitally integrated through full wave rectification and 
50 ms moving average on a duplicate channel. Phrenic burst frequency (f, bursts/min) was 
determined by counting the number of phrenic bursts occurring during 60 s of normocap-
nia immediately preceding the gas challenge, the final 60 s of hypercapnia, and 60 s during 
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normocapnic recovery 5 min after a return to baseline. Phrenic burst amplitude was de-
rived from the mean integrated peak height of all bursts within these 60 s periods, ex-
pressed in arbitrary units within each preparation and as a proportional change within a 
preparation in response to the gas challenge. Neural minute ventilation (NVE) was calcu-
lated as the product of burst frequency and amplitude, again expressed in arbitrary units 
and as a proportional change with treatment (Eldridge, 1971). 
Gas Challenges: Preparations were maintained on normocapnic perfusate for at 
least 1 h. For the gas challenge, gas equilibrating the perfusate was switched in sequence 
to 5-min periods of hypocapnia (96.5 % O2-3.5 % CO2; pH 7.5; PCO2 ≈ 23 mmHg) followed 
by 5-min periods of hypercapnia (91 % O2-9 % CO2; pH 7.2; PCO2 ≈ 60 mmHg) and subse-
quently returned to baseline normocapnia.  The hypercapnic challenge conditions approx-
imated those occurring during a 4 % increase in inspired CO2. 
Pharmacological challenges: Nc- and IHc-pretreated preparations were tested 
with the addition of an antagonist to disrupt particular neurotransmitter signaling mech-
anisms. Pharmacological agents were added after the 60-min normocapnic period, which 
was maintained for an additional 10 min prior to gas challenge. Ketanserin tartrate (5 μM, 
Sigma) was administered to induce CO2 chemoresponsive dysfunction and determine the 
influence of removing ketanserin-sensitive (presumably 5-HT2 receptor-mediated; Corco-
ran et al., 2013) processes on responsiveness to the gas challenge. We have previously 
shown that ketanserin-sensitive mechanisms are critical for chemoresponsiveness in this 
system (Corcoran et al., 2013; Mosher et al., in review). IHc- and Nc-pretreated animals 
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at each of the three developmental ages were tested for ketanserin-insensitive CO2 
chemoresponsiveness. Comparing the effects of these treatments demonstrated the CO2 
chemoresponsiveness of this preparation and the dependence of the IHc-induced re-
sponse on ketanserin-sensitive and insensitive mechanisms. 
Data and statistical analyses: Ventilatory parameters were quantified from the 
recorded neurograms. Frequency (f; the number of bursts per unit time), amplitude (the 
mean peak voltage of bursts), and a neural correlate of minute ventilation (NVE; fre-
quency•amplitude) were calculated from the bursts occurring in the last minute of a gas 
challenge (normocapnia or hypercapnia). As the ventilatory response to hypercapnia may 
not be adequately reflected by only a change in f, we also chose to report amplitude and 
NVE. CO2 responsiveness was quantified as a hypercapnic response percentage calculated 
by expressing the hypercapnic frequency, amplitude or NVE as a percentage of that pa-
rameter’s first normocapnia value, which was recorded at the end of the stabilization pe-
riod.   
Data Parsing: We and others have demonstrated that the in situ rat brainstem 
preparation exhibits clear responsiveness to hypercapnia and provides an appropriate 
model for the study of mechanisms contributing to CO2 chemosensitivity (Corcoran et al., 
2013; Day and Wilson, 2007; Iceman et al., 2013; Mosher et al., in review; Toppin et al., 
2007). These prior studies have illustrated that the response is most clearly manifest in 
changes in burst frequency and the index of minute ventilation, NVE. Our pilot investiga-
tions suggested the possibility that preparations exhibiting a relatively high initial burst 
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frequency have a lower apparent responsiveness to hypercapnia, which suggests a fre-
quency limitation. The present study was designed to determine CO2 chemosensory 
mechanisms, necessitating a focus of responsive preparations free of potential confound-
ing factors. 
To remove the potential confounding influence of dampened CO2 chemorespon-
siveness in preparations with elevated baseline burst frequencies, we subjected the data 
to the following parsing protocol. In preparations exposed to neither pharmacological 
manipulation nor IHc, we plotted the relationship between hypercapnic responsiveness 
and initial burst frequency and determined a linear regression (P < 0.001; R2 = 0.74) de-
scribed by the equation: hypercapnic responsiveness (HcR) = 192 – 3.45 (initial fre-
quency). The highest sensitivity observed in any of these preparations was 184.6. A half-
maximum value was used to determine a threshold initial burst frequency identifying 
preparations for which high initial frequency could confound subsequent CO2 responsive-
ness. Preparations having an initial burst frequency above this threshold were not in-
cluded in the dataset. When so parsed, 3 of 49 preparations (6 %) were removed from 
analyses; a total of 46 preparations contributed to the data set.    
One-way repeated-measures analysis of variance (RM-ANOVA) was used to com-
pare f, amplitude or NVE before and during hypercapnia ketanserin treatment, which 
quantified hypercapnic responsiveness for these three ventilatory parameters under ket-
anserin treatment. One-way ANOVA was used to compare the effect of drug treatment 
on the hypercapnia-induced change in each parameter. For each parameter (f, amplitude 
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and NVE) measured on each animal in each experiment we calculated the % change from 
normocapnia = [(parameter during hypercapnia – parameter during normocapnia) / pa-
rameter during normocapnia)] • 100%. Values reported in the text are mean ± standard 
error. To compare the mean hypercapnic responsiveness for each parameter between 
groups, a Tukey post-hoc analysis was used following a significant ANOVA. 
 
4.4 Results 
Burst discharge recordings: Phrenic neurogram recordings from all preparations were 
characteristic of the eupneic pattern typical of this system (St.-John and Paton, 2000). 
Preparations derived from Nc-pretreated pups before pharmacological manipulation had 
a mean normocapnic burst frequency of 25.2 ± 2.67 bursts/min.  
Hypercapnic responsiveness: Hypercapnic responsiveness was characterized by 
deriving the proportional change from normocapnic values, expressed as a % change 
(Figs. 4.2, 4.3, 4.4). In preparations derived from Nc-pretreated pups assessed for their 
CO2 chemoresponsiveness at P21-35, ketanserin abolished the normalized hypercapnic 
burst frequency, NVE and amplitude and responses (Figs. 4.2, 4.3, 4.4). However, in prep-
arations derived from IHc-pretreated pups that also received ketanserin, when assessed 
for CO2 chemoresponsiveness at P21-35, burst frequency increased 35 ± 6.4 % with hy-
percapnia (P < 0.001; Fig. 4.2), and NVE also increased 24 ± 4.7 % (P < 0.001; Fig. 4.3). In 
preparations derived from Nc-pretreated pups assessed for their CO2 chemoresponsive-
ness at P36-50, ketanserin abolished the normalized hypercapnic burst frequency, NVE 
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and amplitude and responses (Figs. 4.2, 4.3, 4.4). In preparations derived from IHc-pre-
treated pups that received ketanserin when assessed for CO2 chemoresponsiveness at 
P36-50, both burst frequency and NVE were elevated by hypercapnia, 30 ± 6.6 % (P < 
0.001; Fig. 4.2) and 42 ± 15 % (P < 0.001; Fig. 4.3) respectively. In preparations derived 
from Nc-pretreated pups assessed for their CO2 chemoresponsiveness at P51-65, ketan-
serin abolished the normalized hypercapnic burst frequency, NVE and amplitude and re-
sponses (Figs. 4.2, 4.3, 4.4). In preparations derived from IHc-pretreated pups that re-
ceived ketanserin when assessed for CO2 chemoresponsiveness at P51-65, both burst fre-
quency and NVE were elevated by hypercapnia, 11 ± 8 % (P < 0.001; Fig. 4.2) and NVE by 
20 ± 4.6 % (P < 0.05; Fig. 4.3).  
 
4.5 Discussion 
Our study assessed pretreatment with intermittent hypercapnia during postnatal devel-
opment as a modulator of the neuroventilatory response to CO2. We tested the hypoth-
esis that IHc-pretreatment would sufficiently enhance CO2 chemoresponsiveness to over-
come dysfunction pharmacologically induced by ketanserin administration (which was 
previously shown to compromise CO2 chemoresponsiveness; Corcoran et al., 2013; 
Mosher et al., in review) and that this enhancement of CO2 chemoresponsiveness would 
induce long-lasting respiratory plasticity persisting far into life.  
CO2 chemoresponse dysfunction was induced using ketanserin. We have previ-
ously shown that disruption of ketanserin-sensitive mechanisms abolishes CO2 
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chemoresponsiveness in the rat in situ brainstem preparation (Corcoran et al., 2013; 
Mosher et al., in review). In the present study, ketanserin was again used to induce a 
pharmacological dysfunction in the signaling mechanisms that appear to be critical for 
CO2 chemoresponsiveness. Our results confirm that the rat in situ perfused brainstem 
preparation does exhibit CO2 chemoresponsiveness (Corcoran et al., 2013; Day and Wil-
son, 2007; Mosher et al., in review). We also confirmed previous findings that ketanserin-
sensitive mechanisms are critical to CO2 chemoresponsiveness (Corcoran et al., 2013), as 
ketanserin treatment alone abolishes CO2 responsiveness in preparations derived from 
Nc-pretreated animals. The primary influence of ketanserin, in respiratory control mech-
anisms, is as a post-synaptic 5-HT2 receptor antagonist (Awouters, 1985, Corcoran et al., 
2013). Previous studies investigating CO2 chemoresponsiveness using the in situ prepara-
tion have used ketanserin to determine the role of post-synaptic 5-HT2 receptors (Corco-
ran et al., 2013).  As ketanserin not only blocks 5-HT2 receptors but also alpha-1 adrenergic 
(Hoyer et al., 1987) and histamine H1 receptors (Borroto-Escuela et al., 2014), as well as 
5-HT7 and dopamine D1 and D2 receptors with limited affinity (Shen et al., 1993; Wouters 
et al., 1985), Corcoran et al. (2013) acknowledge that the disrupted response to the hy-
percapnic challenge may have resulted from a dependence of chemoresponsiveness on 
alpha-1 adrenergic, histamine H1 or 5-HT7 receptor activation. However, the primary out-
come of ketanserin administration was similar to that resulting from the administration 
of the 5-HT1A receptor agonist (R)-(+)-8-hydroxy-2(di-n-propylamino) tetralin (8-OH-
DPAT; Corcoran et al., 2013) which is commonly used in respiratory studies to inhibit 5-
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HT neuron transmitter release via activation of hyperpolarizing 5-HT1A autoreceptors (St. 
John and Paton, 2000). In addition, a similar outcome to ketanserin was also observed 
following application of the mixed 5-HT1,2 receptor antagonist methysergide (Harris et al., 
2003). Thus, the most likely conclusion is that elimination of the hypercapnic ventilatory 
response by ketanserin is due to disruption of 5-HT processes, and that ketanserin-sensi-
tive influences illustrate 5-HT contributions to hypercapnic responsiveness. We attribute 
our observation of ketanserin-sensitive CO2 chemoresponsiveness to suggest that 5-HT 
neurotransmission is critical for CO2 chemoresponsiveness in this experimental system 
(Corcoran et al., 2013).  
Despite the apparent critical nature of 5-HT-mediated mechanisms confirmed by 
the above findings, central CO2 chemosensitivity is best characterized as a complex sys-
tem function that potentially involves multiple neuron types, brainstem sites, and neuro-
transmitter mechanisms (Feldman et al., 2003; Mitchell et al., 1990; Nattie, 2009; Nattie 
and Li, 2009; Putnam et al., 2004). The possibility that diverse mechanisms contribute to 
such a system function allows for plasticity, providing pH homeostatic regulation despite 
dysfunction in any one mechanism (Feldman et al., 2003). 
We aimed to illustrate that plasticity induced through IHc-pretreatment is long-
lasting and capable of overcoming the chemosensory impairment associated with ketan-
serin-induced dysfunction far into life. We propose that the induced chemoresponsive 
plasticity enhances multiple CO2 chemosensory mechanisms and persists far into life. We 
aimed to induce plasticity within the CO2 chemoresponse system with IHc-pretreatment 
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and thereby facilitate the recruitment of non-ketanserin-sensitive chemosensory mecha-
nisms; we aimed to invoke CO2 chemoresponsiveness when ketanserin-sensitive mecha-
nisms were rendered dysfunctional at various time periods throughout development. 
 We have previously shown that plasticity induced by IHc-pretreatment, responsi-
ble for ketanserin-insensitive responsiveness, was produced through bicuculline- and/or 
saclofen-sensitive GABAA/B receptor-mediated processes not normally critical for 
chemoresponsiveness (Mosher et al., in review). As such, we predict the long-lasting 
chemoresponsive plasticity imparted by IHc-pretreatment may be due to the enhance-
ment of bicuculline- and/or saclofen-sensitive mechanisms. Future studies are needed to 
confirm this prediction. 
Just as different hypoxia stimulus protocols vary in their capacity to evoke respir-
atory plasticity, hypercapnia stimulus protocols also induce respiratory plasticity to vary-
ing degrees. A prior attempt to influence hypercapnic responsiveness with a comparable 
IHc protocol administered between P7 and P14 showed no influence (Steggerda et al., 
2009). However, rat pups exposed to the aforementioned IHc protocol did exhibit an en-
hanced ventilatory response to a subsequent hypoxic challenge. It is likely that the devel-
opmental timing and/or duration of daily IHc stimulus may influence resultant plasticity. 
Our IHc-pretreatment protocol is the first to elicit long-lasting plasticity that enhances the 
hypercapnic ventilatory response, and this enhancement persists far into life (at least 
through P65). 
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Critique of methods: As ketanserin is a receptor antagonist for several neurotrans-
mitter pathways, future work will need to use more specific pharmacological techniques 
to investigate the mechanisms that are being enhanced with IHc-pretreatment. Addition-
ally, the in situ experimental preparation used in the current study was ideal for the first 
attempt at investigating the IHc-pretreatment. However, it will be important for future 
investigations using this IHc-pretreatment protocol to use in vivo experimental prepara-
tions. 
 
4.6 Conclusion 
Our findings are consistent with considerations of central CO2 chemoresponsiveness as a 
system function involving multiple neuron types and neurotransmitter mechanisms thus 
having the potential for considerable plasticity. We propose that IHc-pretreatment is ca-
pable of enhancing multiple CO2 chemosensory mechanisms to result in the maintenance 
of CO2 chemoresponsiveness despite ketanserin-sensitive dysfunction and that this plas-
ticity is long-lasting. We show that IHc-pretreatment induces long-lasting plasticity such 
that CO2 chemoresponsiveness is maintained despite removal of otherwise critical ketan-
serin-sensitive mechanisms.  
 Abnormal homeostatic responses to increased levels of CO2 are associated with 
numerous dangerous or life-threatening disorders. It may be that IHc-induced plasticity 
could enhance homeostatic reflex efficacy and potentially reduce vulnerabilities to these 
conditions. A number of critical factors remain unknown. These include: identification of 
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exact bicuculline- and/or saclofen-sensitive mechanisms contributing to CO2 chemosen-
sory plasticity; changes in ketanserin-sensitive mechanisms with IHc-pretreatment; po-
tential developmental sensitivities to IHc-induced plasticity. The clear potential to induce 
CO2 chemosensory plasticity, however, provides possible targets for therapeutic interven-
tion to reverse or offset CO2 chemoresponsive dysfunction. 
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4.8 Figures 
See below where figures are displayed on full pages. 
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Figure 4.1 Eupneic phrenic ventilatory burst in situ. Typical phrenic neurogram re-
cording with spikes indicating respiratory bursts. During the in situ preparation when the 
organism was exposed to perfusate containing 9 % CO2 (hypercapnia; bottom panel) there 
was an increase in both frequency and NVE (frequency*amplitude) of respiratory events, 
when compared to experiencing 5 % CO2 (normocapnia; top panel). Both of the above 
panels are representative tracings from the last minute of the indicated CO2 treatment. 
Tracings taken from a preparation derived from a Nc-pretreated pup without pharmaco-
logical manipulation. Tracings reported here are the same used in Chapter 2. 
 
 
 
 
5 % CO2 
9 % CO2 
5 sec 
5 sec 
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Figure 4.2 Long-lasting effect of IHc on frequency response to hypercapnia. The two 
leftmost bars are previously reported data (Chapter 2) presented here to demonstrate 
that the frequency response to the hypercapnic challenge is abolished after the admin-
istration of ketanserin (k) in preparations derived from animals that were Nc-pretreated 
(Mosher et al., in review). Hypercapnia failed to increase ventilatory frequency regardless 
of age of assessment in preparations derived from pups that were Nc-pretreated and re-
ceived k (P21-35, n = 7; P36-50, n = 6; P51-65, n = 6). Hypercapnia increased ventilatory 
frequency in preparations derived from IHc-pretreated pups that received k regardless of 
age of assessment (P21-35, n = 10; P36-50, n = 8; P51-65, n = 9). Each bar represents mean 
± SE. Significant increase from normocapnia to hypercapnia (one-way RM-ANOVA): ***P 
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< 0.001. Between groups comparison of difference in hypercapnic responsiveness deter-
mined using one-way ANOVA: †P < 0.05, ††P < 0.01, †††P < 0.001. 
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Figure 4.3 Long-lasting effect of IHc on NVE response to hypercapnia. The two left-
most bars are previously reported data (Chapter 2) presented here to demonstrate that 
the NVE response to the hypercapnic challenge is abolished after the administration of 
ketanserin (k) in preparations derived from animals that were Nc-pretreated (Mosher et 
al., in review). Hypercapnia failed to increase NVE regardless of age of assessment in prep-
arations derived from pups that were Nc-pretreated and received k (P21-35, P36-50 or 
P51-65). Hypercapnia increased NVE in preparations derived from IHc-pretreated pups 
that received k regardless of age of assessment (P21-35, P36-50 or P51-65). Each bar rep-
resents mean ± SE. Significant increase from normocapnia to hypercapnia (one-way RM-
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ANOVA): *P < 0.05, ***P < 0.001. Between groups comparison of difference in hypercap-
nic responsiveness determined using one-way ANOVA: †P < 0.05. 
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Figure 4.4 Long-lasting effect of IHc on amplitude response to hypercapnia. The two 
leftmost bars are previously reported data (Chapter 2) presented here to demonstrate 
that hypercapnia failed to increase the ventilatory amplitude response in animals that 
were Nc-pretreated both with and without ketanserin (k; Mosher et al., in review). Hy-
percapnia failed to increase ventilatory amplitude for preparations derived from IHc-pre-
treated pups that received k at any age (P21-35, P36-50 or P51-65). Administration of k 
also abolished the hypercapnic response for Nc-pretreated animals assessed at all ages 
P21-35, P36-50 or P51-65). Each bar represents mean ± SE. Between groups comparison 
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of difference in hypercapnic responsiveness determined using one-way ANOVA failed to 
reveal any differences between groups. 
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Chapter 5 
Intermittent hypercapnia enhances CO2 responsiveness and overcomes ketanserin-
sensitive dysfunction at various developmental periods1 
5.1 Abstract 
Abnormal homeostatic responses to increased levels of CO2 are associated with numer-
ous dangerous or life-threatening disorders. We have shown that pretreatment with in-
termittent hypercapnia (IHc), induces long-lasting respiratory plasticity, due in part to 
strengthening of bicuculline- and saclofen-sensitive mechanisms. A question remains re-
garding the existence of a critical developmental period in which IHc-pretreatment is 
most beneficial. We tested the hypothesis that IHc-pretreatment during postnatal days 
P12-16 will result in greater increase in CO2 chemoresponsiveness than other develop-
mental periods and that responsiveness will persist despite ketanserin-induced dysfunc-
tion. Rats were exposed to a previously described IHc-pretreatment protocol (Mosher et 
al., in review) for 5 days beginning at P12, P21 or P36. We subsequently assessed CO2/pH 
chemoresponsiveness to a 4 % arterial CO2 challenge using an unanesthetized juvenile rat 
in situ perfused decerebrate brainstem preparation 10-19 days after IHc-pretreatment. 
CO2 chemoresponsive dysfunction was induced pharmacologically with ketanserin. Re-
sults indicate that IHc-pretreatment induced CO2 chemoresponsive plasticity, sufficient 
 
1 Mosher BP, Taylor BE, Harris MB. Intermittent hypercapnia enhances CO2 responsiveness and overcomes 
ketanserin-sensitive dysfunction at various developmental periods. In preparation for publication in 
Respir. Physiol. Neurobiol. 
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to overcome ketanserin-induced CO2 chemoresponsive dysfunction, regardless of devel-
opmental period. There is no critical period for IHc-induced CO2 chemoresponsive plas-
ticity. 
 
5.2 Introduction 
The development of the respiratory system involves a complex, dynamic network of in-
terconnections that can be influenced by many factors and conditions. Much work has 
been conducted providing strong evidence for the inherent plasticity of the brain whereby 
long-lasting or permanent alterations in respiratory control are induced by experience or 
training during critical periods of development. Although training during a specific devel-
opmental period may result in plasticity, such plasticity may not be observed when train-
ing is done during a different developmental period, suggesting a critical period. Ample 
research strongly suggests that such a critical period exists in the respiratory control sys-
tem of the rat (Liu and Wong-Riley, 2002, 2005; Wong-Riley and Liu, 2005). 
In rat at postnatal day 12 (P12), brainstem respiratory nuclei exhibit a distinct, 
sudden fall in the expression of excitatory neurotransmitters and receptors, and a sharp 
rise in the expression of inhibitory neurotransmitters and receptors (Liu and Wong-Riley, 
2002, 2005; Wong-Riley and Liu, 2005). Evidence suggests that P12 may represent a com-
mon sensitive period for most of the brainstem nuclei with known or suspected respira-
tory control functions (Liu and Wong-Riley, 2005). Because of this transient imbalance 
143 
 
between excitatory and inhibitory neurotransmission, the system may be more vulnera-
ble to respiratory training that may induce plasticity during this time period.  
The development of central CO2 chemosensitivity also appears to develop with a 
shift in the degree of responsiveness. Wang and Richerson (1999) observed in medullary 
slices that the percentage of neurons stimulated by hypercapnia was significantly greater 
in slices from rats older than P12 compared to rats younger than P12. In addition, these 
findings were also in parallel to those found in medullary raphé neurons in tissue culture 
(Wang and Richerson, 1999; Wu et al., 2008). These findings may reflect the suggested 
critical period described by the transient imbalance between excitatory and inhibitory 
neurotransmission at P12 (Liu and Wong-Riley, 2005).  
 The purpose of the present study was to investigate the influence of a previously 
described intermittent hypercapnia protocol (IHc: exposure to mild intermittent hyper-
capnia; Mosher et al., in review) at different developmental stages. Such IHc-pretreat-
ment has previously been shown to induce long-lasting (through P65) respiratory plastic-
ity by enhancing subsequent CO2 chemoresponsiveness when IHc-pretreatment is admin-
istered during P12-16 (Mosher et al., in review). The present study is an effort to deter-
mine if a critical period exists in which IHc-pretreatment has its greatest influence. Based 
on the rather drastic respiratory control and chemosensory fluctuations observed at P12, 
we hypothesized that IHc-pretreatment would have its greatest effect when administered 
during P12-16. 
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5.3 Methods 
Experimental groups: All experiments were done in accordance with the guidelines of the 
“Guide for the Care and Use of Laboratory Animals” of the National Institutes of Health 
and were approved by the University of Alaska Fairbanks (UAF) Institutional Animal Care 
and Use Committee. Seven naïve rat dams received normal rat chow and water ad libitum, 
and they were bred with 7 males. Sprague-Dawley rats were used in all experiments (Si-
monson Laboratories). Resulting pups also received food and water ad libitum and were 
housed and maintained in the UAF Animal Care Facility on a 12 h light/dark cycle. A total 
of 36 animals from both sexes were used in these studies.  
Gas pretreatments: Rat pups were pretreated with intermittent hypercapnia (IHc; 
8 consecutive cycles of 5 min 5 % CO2:balance air, followed by 10 min air) for 5 consecu-
tive days beginning at P12, P21 or P36. Entire litters were randomly assigned to receive 
IHc-pretreatment at one of these developmental periods. Because related litter-mates 
rather than randomly assigned individuals were used as experimental subjects, multiple 
litters (2 to 3) received IHc-pretreatment at each developmental period. During IHc-pre-
treatments, dams were separated from pups and the home cage was transported to a 
procedure room adjacent to the animal holding area. Cages were fitted with an airtight 
lid with a gas inflow and outflow. In this manner, litters (ranging from 2 to 10 pups) were 
exposed to isothermic inlet gas flowing at 10 l/min through a countercurrent heat ex-
changer. The gas outlet was connected to 1 m of 5.5 mm internal diameter tubing to pre-
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vent room air infiltration without creating substantial positive pressure within the cham-
ber. For the IHc-pretreatment protocol, a programmable digital timer and solenoid valve 
automatically switched inlet gases between the two sources. This apparatus produced a 
10-min period of normocapnia followed by 8 repeated cycles of 5-min hypercapnia and 
10-min normocapnia. Valve cycling was monitored using a computerized data acquisition 
system (LabChart 7, ADInstruments). Pilot studies indicated that CO2 levels in the enclo-
sure equilibrated with inlet gas concentrations within 90 s, and chamber gas was not mon-
itored during these treatments. After this exposure protocol, cages were removed from 
the enclosure, dams were returned to pups in the home cage and cages were returned to 
the adjacent housing facility. In no cases did pup abandonment occur following these brief 
maternal separations, and patterns and durations of maternal separation were equal be-
tween all treatment groups. Procedures were repeated for the same durations on 5 con-
secutive days, at approximately the same time each day. 
In situ assessment of CO2 chemoresponsiveness: Ten to 19 days following IHc-pre-
treatment, hypercapnic ventilatory responsiveness was assessed using the in situ arteri-
ally perfused brainstem preparation as previously described (Corcoran et al., 2013; Top-
pin et al., 2007, after Paton, 1996). Briefly, animals were anesthetized with isoflurane (5 
%, vaporized in 100 % O2) and pretreated with heparin sodium (500 units, I.P.). Animals 
were bisected subdiaphragmatically and submerged in an ice-chilled artificial cerebral spi-
nal fluid (aCSF) containing (mM in H2O): MgSO4·7H2O, 1; NaH2PO4H2O, 1.25; KCl, 4; Na-
HCO3, 24; NaCl, 115; D-glucose, 10; CaCl2·2H2O, 2). The forebrain rostral to the colliculi 
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was removed by aspiration, and fur, skin and viscera were removed. The diaphragm was 
separated from the body wall with care taken to ensure integrity of the phrenic nerve. 
The preparation was moved to the recording station where the descending aorta was 
cannulated using a double-lumen catheter (Ø 1.25 mm, Braintree Scientific) and perfused 
retrogradely from a reservoir containing 350 ml aCSF (with 13 g/l ficoll 70, Sigma, added 
as an osmotic agent). The perfusate was first equilibrated with 95 % O2-5 % CO2 
(normocapnia, pH 7.4, PCO2 of 33 mmHg). Equilibration mixtures were produced from O2 
and CO2 using a precision gas mixer (GSM3, CWE) and verified with a CO2 analyzer (CD-
3A, Applied Electrochemistry). Normocapnic (baseline) conditions approximated 
normocapnic plasma in vivo.  Lacking hemoglobin, solution hyperoxia (Po2 ≈ 600 mmHg) 
was necessary to maintain O2 content sufficient to meet tissue metabolic demands. This 
unavoidable hyperoxia was constant under all conditions. Perfusate was warmed to 32 
°C, and circulated through a bubble trap and particle filters (25 μm, 45 μm; Millipore) prior 
to entering the aorta. Perfusate passing through the animal was collected and recycled to 
the reservoir. The neuromuscular blocker gallamine triethiodide (20 mg/l), and the vaso-
constriction hormone vasopressin (5 μM) were added to the perfusate. The aortic perfu-
sion pressure was adjusted to 70-80 mmHg using an adjustable perfusate bypass valve 
and a bolus of sodium cyanide (50 μl 0.1 % solution) was injected into the perfusate line 
to transiently stimulate peripheral chemoreceptors (Dutschmann et al., 2000). After par-
tial pulmonectomy, the phrenic nerve was exposed and aspirated into a glass capillary 
suction electrode pulled to a diameter that ensured adequate seal on the nerve.  
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The signal was amplified (×10,000; DAM50, WPI) and filtered (band-pass 300 Hz – 
1 kHz). Using a computerized data acquisition system (Powerlab, ADInstruments), data 
were digitized at 1 k Samples/s and digitally integrated through full wave rectification and 
50 ms moving average on a duplicate channel. Phrenic burst frequency (f, bursts/min) was 
determined by counting the number of phrenic bursts occurring during 60 s of normocap-
nia immediately preceding the gas challenge, the final 60 s of hypercapnia, and 60 s during 
normocapnic recovery 5 min after a return to baseline. Phrenic burst amplitude was de-
rived from the mean integrated peak height of all bursts within these 60-s periods, ex-
pressed in arbitrary units within each preparation and as a proportional change within a 
preparation in response to the gas challenge. Neural minute ventilation (NVE) was calcu-
lated as the product of burst frequency and amplitude, again expressed in arbitrary units 
and as a proportional change with treatment (Eldridge, 1971). 
Gas Challenges: Preparations were maintained on normocapnic perfusate for at 
least 1 h. For the gas challenge, gas equilibrating the perfusate was switched in sequence 
to 5-min periods of hypocapnia (96.5 % O2-3.5 % CO2; pH 7.5; PCO2 ≈ 23 mmHg) followed 
by 5-min periods of hypercapnia (91 % O2-9 % CO2; pH 7.2; PCO2 ≈ 60 mmHg) and subse-
quently returned to baseline normocapnia.  The hypercapnic challenge conditions approx-
imated those occurring during a 4 % increase in inspired CO2. 
Pharmacological challenges: IHc-pretreated preparations were tested with the ad-
dition of an antagonist to disrupt particular neurotransmitter signaling mechanisms. Phar-
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macological agents were added after the 60-min normocapnic period, which was main-
tained for an additional 10 min prior to gas challenge. Ketanserin tartrate (5 μM, Sigma) 
was administered to induce CO2 chemoresponsive dysfunction and determine the influ-
ence of removing ketanserin-sensitive (presumably 5-HT2 receptor-mediated; Corcoran 
et al., 2013) processes on CO2 responsiveness to the gas challenge. We have previously 
shown that ketanserin-sensitive mechanisms are critical for CO2 chemoresponsiveness in 
this system (Corcoran et al., 2013; Mosher et al., in review). IHc-pretreated animals were 
tested for ketanserin-insensitive CO2 chemoresponsiveness. Comparing the effects of 
these treatments demonstrated during which developmental period IHc-pretreatment 
had its greatest influence on ketanserin-insensitive CO2 chemoresponsiveness. 
Data and statistical analyses: Ventilatory parameters were quantified from the 
recorded neurograms. Frequency (f; the number of bursts per unit time), amplitude (the 
mean peak voltage of bursts), and a neural correlate of minute ventilation (NVE; fre-
quency•amplitude) were calculated from the bursts occurring in the last minute of a gas 
challenge (normocapnia or hypercapnia). As the ventilatory response to hypercapnia may 
not be adequately reflected by only a change in f, we also chose to report amplitude and 
NVE. CO2 responsiveness was quantified as a hypercapnic response percentage calculated 
by expressing the hypercapnic frequency, amplitude or NVE as a percentage of that pa-
rameter’s first normocapnia value, which was recorded at the end of the stabilization pe-
riod.   
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One-way repeated-measures analysis of variance (RM-ANOVA) was used to com-
pare f, amplitude or NVE before and during hypercapnia for ketanserin treatment, which 
quantified hypercapnic responsiveness for these three ventilatory parameters under ket-
anserin-induced dysfunction. One-way ANOVA was used to compare the effect of drug 
treatment on the hypercapnia-induced change in each parameter. For each parameter (f, 
amplitude and NVE) in each experiment we calculated the % change from normocapnia = 
[(parameter during hypercapnia – parameter during normocapnia) / parameter during 
normocapnia)] • 100%. Values reported in the text are mean ± standard error. To com-
pare the mean hypercapnic responsiveness for each parameter between groups, a Tukey 
post-hoc analysis was used following a significant ANOVA. 
 
5.4 Results 
Burst discharge recordings: All our recorded phrenic neurograms displayed a “eupneic” 
pattern (Fig. 5.1) characteristic of this preparation (Eldridge, 1971 St.-John and Paton, 
2000), and displayed this pattern throughout normocapnia, hypercapnia and recovery 
from normocapnia and drug treatment.  
Preparations derived from pups that received IHc-pretreatment from P12-16 had 
a mean normocapnic burst frequency of 21.4 ± 2.31 bursts/min. Preparations derived 
from pups that received IHc-pretreatment from P21-25 exhibited a mean normocapnic 
burst frequency of 12.3 ± 1.03 bursts/min and preparations derived from pups that re-
ceived IHc-pretreatment from P36-40 had a mean normocapnic burst frequency of 13.9 
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± 1.36 bursts/min, both of which were lower than preparations derived from pups that 
had received IHc-pretreatment from P12-16 (P < 0.001 and P < 0.01 respectively). Burst 
amplitude was expressed in arbitrary units that were consistent between groups. The 
neural correlate of minute ventilation (NVE) was calculated as the product of burst fre-
quency and burst amplitude. Normocapnic NVE was consistent between groups with the 
exception of preparations derived from pups that received IHc-pretreatment from P12-
16 exhibited a higher NVE than preparations from pups that had received IHc-pretreat-
ment from P21-25 (P < 0.01). 
Response to hypercapnia: All preparations were assessed for ketanserin-insensi-
tive CO2 chemoresponsiveness 10-19 days after IHc-pretreatment at their respective de-
velopmental periods. In preparations derived from pups that received IHc-pretreatment 
from P12-16, hypercapnic responsiveness of f and NVE were 34.5 ± 6.37 % (Fig. 5.2) and 
24.4 ± 4.68 % (Fig. 5.3), respectively. One-way RM-ANOVA indicated that these hypercap-
nia-induced changes were significant (P < 0.001 for f; P < 0.001 for NVE). No significant 
responsiveness was resolved for burst amplitude alone (Fig. 5.4; P = 0.13).  
In preparations derived from pups that received IHc-pretreatment from P21-25, 
hypercapnic responsiveness of f and NVE were 25.3 ± 6.50 % (Fig. 5.2) and 27.0 ± 13.2 % 
(Fig. 5.3), respectively. One-way RM-ANOVA indicated that the hypercapnia-induced 
change in frequency was significant (P < 0.001). No significant responsiveness was re-
solved for NVE (Fig. 5.3; P = 0.12) or burst amplitude alone (Fig. 5.4; P = 0.50).  
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In preparations derived from pups that received IHc-pretreatment from P36-40, 
hypercapnic responsiveness of f and NVE were 26.9 ± 5.01 % (Fig. 5.2) and 19.7 ± 8.89 % 
(Fig. 5.3), respectively. One-way RM-ANOVA indicated that the hypercapnia-induced 
change in frequency was significant (P < 0.001). No significant CO2 responsiveness was 
resolved for NVE (Fig. 5.3; P = 0.10) or burst amplitude alone (Fig. 5.4; P = 0.06).  
 Using a one-way ANOVA, there was no difference in f, NVE or amplitude of ketan-
serin-insensitive CO2 chemoresponsiveness between preparations derived from pups that 
received IHc-pretreatment from P12-16, P21-25 or P36-40.  
 
5.5 Discussion 
Our study assessed pretreating with intermittent hypercapnia (IHc) during various post-
natal developmental periods as a modulator of CO2 chemoresponsiveness. The purpose 
of the present study was to investigate the influence of IHc-pretreatment at different de-
velopmental stages. Such IHc-pretreatment has previously been shown to induce long-
lasting respiratory plasticity by enhancing subsequent CO2 chemoresponsiveness when 
administered during P12-16 (Mosher et al., in review). IHc-pretreatment was adminis-
tered at various developmental stages in an effort to determine if a critical period exists 
in which IHc-pretreatment has its greatest influence. Based on the rather drastic respira-
tory control and CO2 chemosensory fluctuations observed at P12 (Liu and Wong-Riley, 
2005), we hypothesized that IHc-pretreatment would have its greatest effect when ad-
ministered during P12-16. 
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Our results confirm that the rat in situ perfused brainstem preparation does ex-
hibit CO2 chemoresponsiveness (Corcoran et al., 2013; Day and Wilson, 2007). CO2 
chemoresponsive dysfunction was induced using ketanserin. We have previously shown 
that acute disruption of ketanserin-sensitive mechanisms abolishes CO2 chemorespon-
siveness in the rat in situ brainstem preparation (Chapter 2; Corcoran et al., 2013; Mosher 
et al., in review). The primary influence of ketanserin, in respiratory control mechanisms, 
is as a post-synaptic 5-HT2 receptor antagonist (Awouters, 1985, Corcoran et al., 2013). 
Previous studies investigating CO2 chemoresponsiveness using the in situ preparation 
have used ketanserin to determine the role of post-synaptic 5-HT2 receptors (Corcoran et 
al., 2013).  As ketanserin not only blocks 5-HT2 receptors but also alpha-1 adrenergic 
(Hoyer et al., 1987) and histamine H1 receptors (Borroto-Escuela et al., 2014), as well as 
5-HT7 and dopamine D1 and D2 receptors with limited affinity (Shen et al., 1993; Wouters 
et al., 1985), Corcoran et al. (2013) acknowledge that the disrupted response to the hy-
percapnic challenge may have resulted from a dependence of chemoresponsiveness on 
alpha-1 adrenergic, histamine H1 or 5-HT7 receptor activation. However, the primary out-
come of ketanserin administration was similar to that resulting from the administration 
of the 5-HT1A receptor agonist (R)-(+)-8-hydroxy-2(di-n-propylamino) tetralin (8-OH-
DPAT; Corcoran et al., 2013) which is commonly used in respiratory studies to inhibit 5-
HT neuron transmitter release via activation of hyperpolarizing 5-HT1A autoreceptors (St. 
John and Paton, 2000). In addition, a similar outcome to ketanserin was also observed 
following application of the mixed 5-HT1,2 receptor antagonist methysergide (Harris et al., 
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2003). Thus, the most likely conclusion is that elimination of the hypercapnic ventilatory 
response by ketanserin (Chapter 2) is due to disruption of 5-HT processes, and that ket-
anserin-sensitive influences illustrate 5-HT contributions to hypercapnic responsiveness. 
We attribute our observation of ketanserin-sensitive CO2 chemoresponsiveness to sug-
gest that s5-HT neurotransmission is critical for CO2 chemosensitivity in this experimental 
system (Chapter 2; Corcoran et al., 2013). In the present study, ketanserin was again used 
to induce pharmacological dysfunction in the signaling mechanisms that appear to be crit-
ical for CO2 chemoresponsiveness under normal (Nc-pretreated) circumstances (Chapters 
2, 4).  
Pretreating with IHc at each of the developmental periods (P12-16, P21-25 and 
P36-40), greatly augmented subsequent CO2 chemoresponsiveness despite the disruption 
of ketanserin-sensitive mechanisms (Figs. 5.2, 5.3). Although IHc-pretreatment resulted 
in the maintenance of CO2 chemoresponsiveness, this responsiveness was no different 
between the groups regardless of developmental period of IHc-pretreatment administra-
tion.  
We attribute the retention of relatively normal CO2 chemoresponsiveness, over-
coming the expected ketanserin-mediated abolishment of CO2 chemoresponsiveness, to 
plasticity imparted by IHc-pretreatment. The organization of respiratory CO2 
chemoresponsiveness as a system function grants the potential for considerable plastic-
ity. Not only could a particular mechanism play a differential role in overall system sensi-
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tivity under particular conditions, the involvement of multiple mechanisms may allow ho-
meostatic regulation despite partial dysfunction, injury or disease (Feldman et al., 2003; 
Mitchell et al., 1990; Nattie, 2009; Nattie and Li, 2009; Putnam et al., 2004). Thus, if one 
reflex mechanism is dysfunctional, alternative mechanisms may accommodate an appro-
priate response. Our observations indicate that plasticity initiated with IHc-pretreatment 
resulted in CO2 chemoresponsiveness mediated by mechanisms other than the ketan-
serin-sensitive mechanisms normally critical for CO2 responsiveness. In addition, the IHc-
induced enhancement of CO2 chemoresponsiveness does not appear to have a critical pe-
riod. Thus, IHc-pretreatment induces plasticity, sufficient to overcome ketanserin-sensi-
tive dysfunction, regardless of developmental period. It may be that the induced ketan-
serin-insensitive plasticity is bicuculline- and/or saclofen-sensitive, but future studies are 
needed to investigate this prediction. 
Prior attempts to influence hypercapnic responsiveness showed no influence 
when a comparable IHc protocol was conducted between P7 and P14 (Steggerda et al., 
2009). It is likely that the developmental timing and/or nature of the IHc stimulus influ-
ences resultant plasticity. 
We show that IHc-induced plasticity, nondiscriminative of the developmental pe-
riod in which it is administered, is sufficient to overcome profound CO2 chemoresponsive 
dysfunctions produced by pharmacological disruption of critical ketanserin-sensitive 
mechanisms. It may be that IHc-induced plasticity to enhance CO2 chemoresponsiveness 
could enhance pH homeostatic reflex efficacy and potentially reduce vulnerabilities to 
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conditions associated with abnormal CO2 chemoresponsiveness, such as the Sudden In-
fant Death Syndrome. A number of critical factors remain unknown. These include: iden-
tification of exact mechanisms contributing to enhanced CO2 chemoresponsiveness plas-
ticity; changes in ketanserin-sensitive mechanisms with IHc-pretreatment; influences of 
different lengths of IHc protocols. The clear potential to induce chemosensory plasticity, 
however, provides possible targets for therapeutic intervention to reverse or offset CO2 
chemosensory dysfunction. 
Critique of methods: It is important to note that although IHc-pretreatments were 
administered at the various developmental periods (P12-16, P21-25 or P36-40), Nc-pre-
treatments were not administered to animals at these developmental periods. Although 
we predict that Nc-pretreatment at these developmental periods will not alter CO2 
chemoresponsiveness, future investigations will need to confirm these predictions.  
 
5.6 Conclusions 
The respiratory control system is capable of exhibiting plasticity induced by experience or 
training during periods of development. The same experience occurring outside of a crit-
ical period may have little or no lasting effect, indicating that the plasticity depends on 
time windows during ontogeny when development can be altered in response to the ex-
ternal environment. Such a critical period does not exist for our IHc-preconditioning pro-
tocol under the experimental conditions that were used.  
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5.8 Figures 
See below where figures are displayed on full pages. 
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Figure 5.1 Eupneic phrenic ventilatory burst in situ for preparations derived from 
animals that were pretreated with IHc at various developmental periods. Typical 
phrenic neurogram recordings with spikes indicating ventilatory bursts. When the in situ 
preparations were exposed to perfusate containing 9 % CO2 (hypercapnia; right panels) 
there was an increase in both frequency and NVE (frequency*amplitude) of ventilatory 
events compared to 5 % CO2 exposure (normocapnia; left panels) for animals IHc-pre-
treated at P12-16 and P36-40. Preparations derived from pups that received IHc-pretreat-
ment at P21-25 exhibited an increase in frequency when exposed to hypercapnia, but no 
increase in NVE was observed. All panels are representative records of the last minute of 
the indicated CO2 treatment. 
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Figure 5.2 IHc enhances frequency response of hypercapnia regardless of develop-
mental period in which it is administered. T1 = IHc-pretreatment from P12-16, T2 = IHc-
pretreatment from P21-25, T3 = IHc-pretreatment from P36-40. Hypercapnia increased 
ventilatory frequency, normalized to normocapnia, in preparations, derived from pups 
that received IHc-pretreatment at T1, and also received ketanserin (k) 10-19 days later 
during the in situ preparation (n = 10). Hypercapnia also increased ventilatory frequency 
in preparations derived from pups that received IHc-pretreatment at T2, and also received 
k 10-19 days later (n = 11). Hypercapnia also increased ventilatory frequency in prepara-
tions derived from pups that received IHc-pretreatment at T3, and also received k 10-19 
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days later (n = 15). Bars on left depict data previously described (Chapter 2, Mosher et al., 
in review) indicating that preparations that received Nc-pretreatment (normocapnic ex-
posures) from P12-16 exhibit a significant response to hypercapnia. However, when prep-
arations derived from Nc-pretreated animals that also received k (Nc + k) the hypercapnic 
response is significantly reduced. Thus, under control conditions (Nc-pretreated), k abol-
ishes the hypercapnic response (Nc + k bar). However, in preparations from animals that 
are pretreated with IHc, regardless of developmental period (T1, T2 or T3), that also re-
ceive k, the hypercapnic response persists. Each bar represents mean ± SE. Significant 
increase from normocapnia to hypercapnia (one-way RM-ANOVA): ***P < 0.001. Using 
one-way ANOVA, no difference was found between hypercapnic responsiveness of the 
groups (T1, T2, T3). 
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Figure 5.3 IHc enhances NVE response of hypercapnia when administered at T1. 
T1 = IHc-pretreatment from P12-16, T2 = IHc-pretreatment from P21-25, T3 = IHc-pre-
treatment from P36-40. Hypercapnia increased ventilatory NVE, normalized to 
normocapnia, in preparations derived from pups that received IHc-pretreatment at T1 
and received ketanserin (k) 10-19 days later during the in situ preparation (n = 10). Bars 
on left depict data previously described (Chapter 2, Mosher et al., in review) indicating 
that preparations that received Nc-pretreatment (normocapnic exposures) exhibit a sig-
nificant response to hypercapnia. However, when Nc-pretreated animals also received k 
(Nc + k) the hypercapnic response is significantly reduced. Thus, under control conditions 
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(Nc-pretreated), k abolishes the hypercapnic response (Nc + k bar). Each bar represents 
mean ± SE. Significant increase from normocapnia to hypercapnia (one-way repeated-
measures ANOVA): *P < 0.05; ***P < 0.001. Using one-way ANOVA, no difference was 
found between hypercapnic responsiveness of the groups. 
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Figure 5.4 IHc fails to enhance amplitude response of hypercapnia regardless of de-
velopmental period in which it is administered. T1 = IHc-pretreatment from P12-16, T2 
= IHc-pretreatment from P21-25, T3 = IHc-pretreatment from P36-40. Hypercapnia failed 
to increase ventilatory amplitude, normalized to normocapnia, regardless of the develop-
mental period in which IHc-pretreatment was administered when k was also adminis-
tered. Each bar represents mean ± SE. Using one-way ANOVA, no difference was found 
between hypercapnic responsiveness of the groups. 
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Chapter 6 
Conclusions 
6.1 Summary of results 
My results demonstrate the impressive ability of our intermittent hypercapnia (IHc) pro-
tocol to induce respiratory plasticity. This is the first time an IHc protocol has been shown 
to enhance the subsequent response to a hypercapnic challenge. The plasticity induced 
by IHc-pretreatment is capable of overcoming ketanserin-sensitive dysfunction normally 
associated with abolishment of CO2 chemoresponsiveness (Chapter 2; Corcoran et al. 
2013; Mosher et al., in review). The plasticity that is induced by the IHc protocol is also 
capable of overcoming a partial, chronic dietary tryptophan (Trp) restriction that normally 
results in a measurable reduction of CO2 chemoresponsiveness (Chapter 3; Penatti et al., 
2011). We, and others (Bavis, 2011; Penatti et al., 2011), believe this Trp restriction model 
be biologically relevant. I predict that, based on previous findings by Penatti et al. (2011), 
this Trp restriction resulted in a partial reduction in brainstem serotonin (5-HT). Using 
pharmacological methods I show that IHc-pretreatment acts to enhance bicuculline- 
and/or saclofen-sensitive (potentially GABAergic) contributions to central CO2 
chemoresponsiveness (Chapter 2). This enhancement of CO2 responsiveness is so robust 
that despite two different severities of CO2 chemoresponsive dysfunction, an appropriate 
response to a hypercapnic challenge is retained when animals were pretreated with IHc. 
In addition, the induced plasticity is long-lasting such that animals pretreated with the IHc 
protocol retain an appropriate response to a hypercapnic challenge far into adult life (at 
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least through P65), even despite disruption of ketanserin-sensitive mechanisms normally 
critical for the hypercapnic response (Corcoran et al., 2013). Furthermore, as the admin-
istration of the IHc-pretreatment at numerous developmental periods (P12-16, P21-25 or 
P36-40) resulted in the retention of the hypercapnic response despite disruption of ket-
anserin-sensitive mechanisms, it appears that IHc-pretreatment induces profound respir-
atory plasticity regardless of the developmental period in which it was administered. 
Taken together, these findings demonstrate the impressive ability of our IHc-pretreat-
ment protocol to induced respiratory plasticity overcoming various CO2 chemoresponsive 
dysfunctions. 
Although much work has been done in an effort to reveal the specific neuronal 
types and mechanisms involved in the central response to hypercapnia, much less re-
search has been devoted to developing potential therapeutics to combat the array of dis-
orders and diseases associated with the inappropriate response to CO2. The findings de-
scribed in the manuscripts within the current dissertation present a potential therapy to 
reverse an abnormal pH homeostatic reflex associated with numerous respiratory dis-
eases. The clear potential to induce respiratory chemoresponsive plasticity provides pos-
sible targets for therapeutic intervention to reverse or offset CO2 chemoresponsive dys-
function. 
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6.2 Future directions 
The findings reported in the current dissertation describe exciting research, but much 
work remains to be done and a number of critical factors remain unknown. These include, 
but are not limited to: identification of exact mechanisms contributing to enhanced CO2 
chemoresponsiveness plasticity; changes in ketanserin-sensitive and bicuculline- and/or 
saclofen-sensitive mechanisms with IHc-pretreatment; and influences of different lengths 
of IHc-pretreatment protocols.  
 The in situ perfused brainstem preparation was a very useful preparation in which 
to test the efficacy of our IHc-pretreatment protocol. However, it is important to replicate 
the described experiments using an in vivo preparation. If, presumably, the administered 
IHc-pretreatment protocol also functions to enhance CO2 chemoresponsiveness in vivo, it 
would be important to then test IHc-pretreatment efficacy in another animal preparation 
(e.g. swine). In addition, it would be very informative to employ genetic tools such as 
transgenic and optogenetic animals as well as various electrophysiological techniques 
(e.g. patch clamp) to further investigate the influence of IHc-pretreatment. If my findings 
are replicated across several species and preparations, a similar protocol could potentially 
be explored for use in human. 
 Naturally, much research is necessary before potential therapeutics are able to be 
used in humans. However, and importantly, the low level of CO2 utilized in our IHc-pre-
treatment protocol (5 %) is safe.  
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6.3 Critique of methods 
The ideal experimental design in studies using rodent neonates would be to assign one 
pup from each litter to an experimental group. However I felt, as did the IACUC, that such 
a design would have resulted in the unacceptable sacrifice of a very large number of re-
search animals. To minimize costs, both in terms of ﬁnancial and animal welfare issues, I 
chose to accept the limitation of using all pups from each litter in the same experimental 
group.  
 Rat pups are poikilothermic and must remain in close proximity to either dams or 
litter mates to avoid hypothermia. As a result, the gas pretreatment protocol could only 
be administered to entire litters.  Since some of the dams were maintained on a trypto-
phan-deficient diet, it was impossible to mix pups after birth. In addition, such cross fos-
tering methods are notoriously unsuccessful, and generally result in dam infanticide or 
pup abandonment. These restrictions required that all pups from each litter were treated 
the same. 
 To address the possibility of selection bias and reduce the potential complication 
of pseudoreplication, multiple litters were assigned to each experimental condition and 
all pups in all litters were used. I was not able to create a balanced experimental design 
to include all pharmacological manipulations in pups of a given litter because of the great 
variation in the number of pups per litter. In addition, when investigating whether or not 
a critical period existed in which the IHc-pretreatment protocol had its greatest influence, 
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gas exposures were administered at different developmental periods and tested for re-
sponsiveness at different latencies.  Again, there was no way to balance this design within 
a litter without introducing new and much more profound confounding influences result-
ing from altering litter social structure in some cases and not in others.   
Although it may have been possible to redesign the purely pharmacological stud-
ies, all experimental protocols needed to be comparable with the dietary tryptophan re-
striction design, and thus all experimental designs were required to be identical. I was not 
able to use litter as a variable assessed in a true analysis of covariance as too few litters 
were assigned to some experimental conditions. I made efforts to address this unavoida-
ble lack of independence between sibling pups when performing the statistics by includ-
ing litter as a random factor while using a mixed-design ANOVA and a nested ANOVA. 
However, because of the variable number of pups in each litter and also the variable num-
ber of litters in each experimental group, I was not able to use these statistical methods.  
Despite these necessary, but potentially concerning shortcomings in experimental 
design, no single litter of pups presented as an outlier. Taking these issues into account, 
the lack of independence between sibling pups must be considered when interpreting the 
data. Future studies will need to randomly assign each pup to a different pharmacological 
group to address such issues of independence between siblings. 
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6.4 Potential inadvertent IHc exposures during breast feeding protect against SIDS 
There is considerable evidence indicating that infants exclusively breast fed at discharge 
from the hospital have a significantly lower risk of succumbing to SIDS than infants not 
breast fed, after controlling for potential confounders (Alm et al., 2002; Ford et al., 1993; 
Steele and Langworth, 1966). In addition, there has been a significant upward trajectory 
of mothers choosing to breast feed, and to breast feed for a greater number of months 
since 1992, correlated with a roughly 50 % decline of SIDS cases (Fig. 6.1; McKenna and 
McDade, 2005). The mechanism of the protective effect of breast feeding is not clear. 
One suggested possibility is that infants who are breast fed have a lower incidence of 
infections due to a stronger immune system because of breast milk consumption and this 
increased strength of immune system results is a form of protection against SIDS 
(McKenna and McDade, 2005). Although this may be, I suggest an alternative explanation 
for the protective role of breast feeding with regard to SIDS.  
When an infant is breast fed, the face is in very close proximity to the breast, re-
stricting diffusion of atmospheric gases around the infant. Thus, the infant may be re-
breathing its own previously expired air (≈ 5 % CO2; Bolton et al., 1993) and exposing itself 
to increased levels of CO2. In addition, the mother will undoubtedly look down at the 
breast feeding infant and breathe down on the infant periodically, again increasing the 
level of CO2 to which the infant is being exposed. It has been suggested an infant rebreath-
ing its own air results in exposure of about 5 % CO2 (Bolton et al., 1993), which happens 
to be the same level of CO2 I utilized in my IHc-pretreatment protocol. Alternatively, when 
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an infant is bottle fed, the level of CO2 rebreathing may be less, potentially resulting in a 
rather constant level of normocapnic conditions. So, the protective effect of breast feed-
ing may be due to the intermittent exposures of hypercapnia. These exposures may 
strengthen CO2 chemoresponsiveness such that if an infant encounters a harmful envi-
ronmental stressor (e.g. being put to sleep in the prone position), it will be able to respond 
and appropriately maintain pH homeostasis.  
To begin to test this hypothesis, it will first be necessary to measure CO2 levels 
around the faces of infants that are breast feeding and compare these with infants that 
are bottle feeding. In addition, appropriate control groups must also be considered. If it 
does appear that infants who breast feed are exposed to higher levels of CO2, compared 
to bottle fed infants, and these breast fed infants are less likely to succumb to SIDS, nurses 
and physicians may be able to someday instruct caregivers of newborns to advertently 
breathe on their infants throughout the day to expose them to intermittent exposures of 
increased levels of CO2. This simple instruction may enhance CO2 chemoresponsiveness 
and protect against diseases and disorders known to influence the important pH homeo-
static reflex.  
 
6.5 Relevance of current dissertation 
Given the wide range of diseases and disorders associated with abnormal or dysfunctional 
homeostatic control of CO2/pH in the blood, the research described in the current disser-
tation lays groundwork for much research in the future. As SIDS remains the largest killer 
174 
of infants under the age of one year (Moon et al., 2007; Willinger et al., 1991), the finding 
of a treatment or therapy is imperative. The IHc-pretreatment protocol described here 
may be the first step in the direction of such a therapy. That being said, much research is 
needed before a similar IHc-pretreatment protocol can be used to potential protect in-
fants against disorders associated with a dysfunctional CO2 chemoresponsive, like SIDS. 
 The laboratory of Dr. Michael Harris at the University of Alaska Fairbanks focuses 
on central CO2 chemosensitivity. Most of the previous work in the Harris laboratory has 
focused on determining the cellular and network interactions involved in the response to 
hypercapnia, with a special interest in the role that the medullary raphé of the mamma-
lian brainstem plays. Previous work done in the Harris laboratory describing 5-HT and 
GABA neuronal responses to hypercapnia led to the idea for the work described in the 
current dissertation.  
 Although the Harris laboratory does not primarily focus on the interaction of nu-
trition and the central response to hypercapnia, repeating and confirming the findings 
previously described by Penatti et al. (2011; Chapter 3) has demonstrated a biologically 
relevant model for SIDS that may be quite helpful in the Harris laboratory in the future. 
In addition, although historically the Harris laboratory has not necessarily focused on de-
veloping treatments for potential clinical use, my findings reported in this dissertation 
may provide a platform in which future students in the Harris laboratory can base their 
investigations. 
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6.7 Figures 
See below where figures are displayed on full pages. 
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Figure 6.1 Protective effect of breast feeding with respect to SIDS. United States 
SIDS rates and national breast feeding rates (in-hospital and at 6 months) from 1985–
1997. The data show that the dramatic decline in SIDS cases, beginning in 1992, occurred 
in relation to a significant upward trajectory of increased breast feeding. It may be that 
breast feeding enhances chemoresponsiveness of infants. Modified from McKenna and 
McDade, 2005. 
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